,Rank,NCTId,Condition,BriefTitle,InterventionName
0,1,NCT04125329,Mesenchymal Stem Cells|Diabetic Nephropathy,Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy,Human umbilical cord mesenchymal stem cells
1,2,NCT01221428,Ulcerative Colitis|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis,Umbilical Cord Mesenchymal Stem Cells
2,3,NCT03558334,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia,Transplantation of mesenchymal stem cell|No transplantation of mesenchymal stem cell
3,4,NCT03765957,Psoriasis,Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells,Mesenchymal Stem Cells
4,5,NCT01219465,"Diabetes Mellitus|Diabetes Mellitus, Type 1|Mesenchymal Stem Cells|Umbilical Cord",Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus,umbilical cord mesenchymal stem cells
5,6,NCT02824393,Urticaria|Autoimmune Diseases|Immune System Diseases|Skin Diseases,Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria,Autologous mesenchymal stem cell
6,7,NCT02118519,"Articular Cartilage Disorder of Knee|Osteoarthritis, Knee",Mesenchymal Stem Cells in Knee Cartilage Injuries,Autologous Mesenchymal Stem Cells
7,8,NCT04073472,"Crohn's Disease|Fistula|Anal Fistula|Pouch, Ileal|Pouches, Ileoanal",Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's,mesenchymal stem cells (MSCs)
8,9,NCT02112500,"Respiratory Distress Syndrome, Adult",Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure,Mesenchymal Stem Cell
9,10,NCT03601416,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia,Transplantation of mesenchymal stem cell|No Transplantation of Mesenchymal Stem Cell
10,11,NCT01219452,Dilated Cardiomyopathy,Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy,umbilical cord mesenchymal stem cells
11,12,NCT03106662,Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies,mesenchymal stem cells|cyclophosphamide administration
12,13,NCT02302599,Type 2 Diabetes|Mesenchymal Stem Cells,Mesenchymal Stem Cells to Treat Type 2 Diabetes,Umbilical cord mesenchymal stem cells|Controlled suspension liquid
13,14,NCT02804945,Blood And Marrow Transplantation|Adult Respiratory Distress Syndrome,Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies,Mesenchymal Stem Cells (MSCs)
14,15,NCT03778333,Autologous Mesenchymal Stem Cells|Multiple Sclerosis,Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden,Autologous mesenchymal stem cells
15,16,NCT01068951,Type 1 Diabetes,Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells,Mesenchymal stem cells
16,17,NCT01694927,Spinal Cord Injury,Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients,Autologous Mesenchymal Stem Cells
17,18,NCT04318600,Lupus Nephritis|Mesenchymal Stem Cells,Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis,human amniotic mesenchymal stem cell
18,19,NCT01297972,Aplastic Anemia,Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia,Intravenous bone marrow mesenchymal stem cells infusion
19,20,NCT02140528,Tibial Fracture,Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures,Mesenchymal stem cell injection|Placebo
20,21,NCT01224327,Liver Cirrhosis|Radiology|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients,umbilical cord Mesenchymal Stem Cells|Conserved therapy
21,22,NCT01763086,"Stem Cell Transplantation, Hematopoietic|Mesenchymal Stem Cells|Poor Graft Function|Hematological Diseases",Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant,Mesenchymal stem cells
22,23,NCT00504803,Hematological Malignancies,Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease,Mesenchymal stem cell infusion
23,24,NCT01788059,Nonunion Fracture,The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital,injection the mesenchymal stem cell in non union site
24,25,NCT03863002,"Liver Failure, Acute on Chronic",Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure,Mesenchymal Stem Cell
25,26,NCT01763099,Hematopoietic Stem Cell Transplantation|Mesenchymal Stem Cells|Umbilical Cord Blood|Graft Failure|Hematological Diseases,Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure,Mesenchymal stem cells|Mesenchymal stem cells and cord blood
26,27,NCT01956903,Chronic Graft-Versus-Host Disease,Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.,Allogenic Mesenchymal Stem Cell
27,28,NCT04078308,"Diabetes Mellitus|Diabetes Mellitus, Type 1|Diabetes Mellitus, Insulin-Dependent",Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients,Intravenous Injection of autologous mesenchymal stem cells|Intravenous injection of placebo
28,29,NCT03130374,Tracheal Stenosis|Laryngeal Stenosis|Mesenchymal Stem Cells,Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells
29,30,NCT02285673,Duchenne Muscular Dystrophy,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,Umbilical Cord Mesenchymal Stem Cell
30,31,NCT02166489,Chronic Renal Failure|Polycystic Kidney Disease,Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease,Intravenous injection autologous mesenchymal stem cells
31,32,NCT01216865,Diabetic Foot|Critical Limb Ischemia|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot,umbilical cord mesenchymal stem cells|Standard Therapy
32,33,NCT01941394,Graft-versus-host Disease|Relapse,Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation,Mesenchymal stem cells
33,34,NCT02824653,Graft Versus Host Disease,Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD,Mesenchymal Stem Cells
34,35,NCT01429012,Nonunion Fracture,Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting,Mesenchymal Stem Cells|Culture medium without MSC.
35,36,NCT03683953,Safety Issues|Effect of Drugs,The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells,mesenchymal stem cells therapy|0.9% sodium chloride
36,37,NCT03068988,Rotator Cuff Tear,Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions,mesenchymal stem cells|without mesenchymal stem cells
37,38,NCT01946048,Ischemic Cardiomyopathy,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy,mesenchymal stem cells
38,39,NCT01377870,Multiple Sclerosis,Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis,intravenous injection of mesenchymal stem cells|injection of cell free media
39,40,NCT02482194,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study,mesenchymal stem cells
40,41,NCT02755922,Mandibular Fractures,Bone Regeneration With Mesenchymal Stem Cells,Application of autologous mesenchymal stem cells
41,42,NCT02945462,Erectile Dysfunction,Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED),autologous mesenchymal stem cells
42,43,NCT02172885,Osteogenesis Imperfecta,Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta,Mesenchymal Stem Cells
43,44,NCT02116634,Amyotrophic Lateral Sclerosis,Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis,mesenchymal stem cell
44,45,NCT05160831,Knee Osteoarthritis,Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis,Human umbilical cord mesenchymal stem cells
45,46,NCT05468502,Idiopathic Pulmonary Fibrosis,Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF),Human umbilical cord mesenchymal stem cell injection
46,47,NCT02247973,Severe Aplastic Anemia,Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.,mesenchymal stem cells|mesenchymal stem cells
47,48,NCT02249676,Devic's Syndrome|Devic's Neuromyelitis Optica|Devic Syndrome|Devic's Disease|Devic Disease,Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders,Autologous mesenchymal stem cells
48,49,NCT04441658,Type 2 Diabetes|Mesenchymal Stem Cells,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus,Umbilical Cord Mesenchymal Stem Cells|saline
49,50,NCT00953485,Sjogren's Syndrome|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS),Allogeneic Mesenchymal Stem Cells (AlloMSC)
50,51,NCT04351932,Osteo Arthritis Knee,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis,bone marrow mesenchymal stem cells|Adipose Mesenchymal stem cells|bone marrow & adipose mesenchymal stem cells injection
51,52,NCT03956719,Knee Osteoarthritis,Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|abdominal liposuction
52,53,NCT01157403,Evidence of Liver Transplantation,Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes,Autologous transplantation
53,54,NCT04414592,Lumbar Disc Degeneration|Lumbar Disc Herniation,Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease,human umbilical cord mesenchymal stem cells
54,55,NCT01902082,ARDS,Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome,Mesenchymal stem cells|Placebo
55,56,NCT02409940,Renal Transplant Rejection,To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients,Mesenchymal Stem Cells
56,57,NCT01676441,Spinal Cord Injury,Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury,cellgram-spine
57,58,NCT01775774,Acute Respiratory Distress Syndrome,Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
58,59,NCT03668171,Acute-On-Chronic Liver Failure,Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure,mesenchymal stem cell transplantation or placebo infusion via peripheral vein
59,60,NCT04446897,"Periodontitis, Chronic",Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction,mesenchymal stem cells|standard treatment
60,61,NCT03346967,Hormone Deficiency,Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency,adipose-derived mesenchymal stem cells
61,62,NCT04791878,Perianal Fistula Due to Crohn's Disease (Disorder),Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease,Mesenchymal stem cells
62,63,NCT02344849,Erectile Dysfunction,Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction,mesenchymal stem cell
63,64,NCT03219801,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus,mesenchymal stem cells
64,65,NCT02266394,Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Disease|Chronic Kidney Disease,Hypoxia and Inflammatory Injury in Human Renovascular Hypertension,Mesenchymal stem cell|Mesenchymal stem cell delivery with stent placement
65,66,NCT03645525,Bronchopulmonary Dysplasia,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD),Human Umbilical Cord-derived Mesenchymal stem cell|placebo
66,67,NCT01504464,Osteoarthritis,The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis,mesenchymal stem cell|Placebo
67,68,NCT00659620,Kidney Transplant|Chronic Allograft Nephropathy,Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy,mesenchymal stem cell
68,69,NCT01877759,Liver Cirrhosis,A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis,Mesenchymal stem cell
69,70,NCT01962233,Hypoxic Ischemic Encephalopathy,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy,mesenchymal stem cells
70,71,NCT02460770,Chronic Myocardial Ischemia,Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device,Autologous mesenchymal stem cells
71,72,NCT03055078,Aplastic Anemia,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia,mesenchymal stem cells
72,73,NCT03668145,Primary Biliary Cirrhosis,Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis,mesenchymal stem cell transplantation or placebo infusion via peripheral vein
73,74,NCT01360164,Hereditary Ataxia,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia,human umbilical cord mesenchymal stem cells
74,75,NCT03358654,Umbilical Cord Bleeding|Knee Osteoarthritis,Evaluating Safety and Efficacy of Mesenchymal Stem Cells From Umbilical Cord,mesenchymal stem cells from umbilical cord
75,76,NCT04302519,COVID-19,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,Dental pulp mesenchymal stem cells
76,77,NCT00734396,Organ Transplantation,Mesenchymal Stem Cells and Subclinical Rejection,Mesenchymal stem cell infusion
77,78,NCT01765634,Acute Graft-versus-host Disease,Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease,Mesenchymal stem cells|Non-mesenchymal stem cells
78,79,NCT03383081,"Osteoarthritis, Knee",The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,Low dose mesenchymal stem cells|High dose mesenchymal stem cells|Intraarticular injection
79,80,NCT01765660,Chronic Graft-versus-host Disease,Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease,Mesenchymal stem cells|Non-mesenchymal stem cells
80,81,NCT04446884,Stress Urinary Incontinence,Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols
81,82,NCT02181712,Lung Transplant Reject|Bronchiolitis Obliterans,Mesenchymal Stem Cell Therapy for Lung Rejection,Mesenchymal stem cell 0.5|Mesenchymal stem cell 1.0
82,83,NCT01056471,"Autoimmune Diseases|Immune System Diseases|Demyelinating Diseases|Nervous System Diseases|Demyelinating Autoimmune Diseases, CNS|Autoimmune Diseases of the Nervous System",Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis,Autologous mesenchymal stem cells from adipose tissue.|Autologous mesenchymal stem cells from adipose tissue.
83,84,NCT02414295,Klinefelter Syndrome|Azoospermia,Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection,Mesenchymal stem cell injection
84,85,NCT02440074,Degenerative Disc Disease,Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV),Autologous bone marrow mesenchymal stem cells
85,86,NCT01649700,The Sequelae Caused by Severe Brain Injury,Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells,autologous adipose-derived mesenchymal stem cells
86,87,NCT02963727,Knee Osteoarthrosis,Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,Wharton Jelly derived mesenchymal stem cell
87,88,NCT04194671,Acute Kidney Injury|Mesenchymal Stem Cells,Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury,Mesenchymal stem cells|Saline
88,89,NCT02966951,Knee Osteoarthrosis,Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,Adipose tissue derived mesenchymal stem cell
89,90,NCT01157650,Crohn Disease,Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue,Autologous mesenchymal stem cells
90,91,NCT02763423,"Ketoacidosis, Diabetic",Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis,umbilical cord mesenchymal stem cell
91,92,NCT04519671,Perianal Crohn Disease|Perianal Fistula|Crohn Disease,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Mesenchymal Stem Cells|Placebo
92,93,NCT01741090,Alcoholic Liver Cirrhosis,The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis,mesenchymal stem cell injection
93,94,NCT03184935,Myelodysplastic Syndromes,Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS),Allogeneic umbilical cord mesenchymal stem cells|Decitabine
94,95,NCT04519697,Rectovaginal Fistula|Crohn Disease|Crohn Disease of Vulva|Rectolabial; Fistula,Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease,Mesenchymal Stem Cells|Placebo
95,96,NCT03357575,Knee Osteoarthritis,The Comparison of Efficacy and Safety of the Mesenchymal Stem Cells From Adipose and Hyaluronic Acid,Mesenchymal Stem Cells from adipose|Hyaluronic Acid
96,97,NCT02213705,SYSTEMIC SCLERODERMA|ALLOGENEIC MESENCHYMAL STEM CELLS|ADULT,Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells,INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
97,98,NCT03180463,Osteonecrosis of Femoral Head,The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|core decompression
98,99,NCT03343782,Type 2 Diabetes Mellitus,Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes,Expanded autologous bone marrow-derived mesenchymal stem cell
99,100,NCT03186456,Cerebral Infarction,The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction,Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|Aspirin Tablet
100,101,NCT04104412,Lumbar Discogenic Pain,The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain,human umbilical cord mesenchymal stem cell
101,102,NCT02484950,Full Thickness Rotator Cuff Tear,Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair,Mesenchymal stem cell augmentation in rotator cuff repair|Standard arthroscopic rotator cuff repair
102,103,NCT02866721,Cystic Fibrosis,Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis,Mesenchymal Stem Cells
103,104,NCT04520022,Recessive Dystrophic Epidermolysis Bullosa,Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB,Human Umbilical Cord Blood-derived Mesenchymal Stem Cells
104,105,NCT04234750,Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites,Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites,mesenchymal stem cell conditioned medium-derived pleiotropic factor
105,106,NCT01730547,Multiple Sclerosis,Mesenchymal Stem Cells for Multiple Sclerosis,Autologous mesenchymal stem cells
106,107,NCT01573923,Liver Cirrhosis,Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis,mesenchymal stem cells|Conventional therapy
107,108,NCT02387749,Diabetic Peripheral Neuropathy,Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .,mesenchymal stem cells
108,109,NCT01854957,Multiple Sclerosis,MEsenchymal StEm Cells for Multiple Sclerosis,Autologous Mesenchymal Stem Cells
109,110,NCT00659217,Lupus Nephritis,Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis,mesenchymal stem cell
110,111,NCT02834858,Peripheral Vascular Disease|Ischemia|Diabetic Foot,Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications,Umbilical Cord Mesenchymal Stem Cells|saline
111,112,NCT01446614,Parkinson's Disease,Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease,bone marrow derived mesenchymal stem cells
112,113,NCT01932164,Cleft Lip and Palate,Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients,maxillary alveolar graft by tissue engineering|Bone tissue engineering using mesenchymal stem cells
113,114,NCT01446640,Spinal Cord Injury,Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury,bone marrow derived mesenchymal stem cells
114,115,NCT01228266,Multiple Sclerosis,Mesenchymal Stem Cell Transplantation in MS,autologous mesenchymal stem cells
115,116,NCT01919827,Idiopathic Pulmonary Fibrosis,Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis,Endobronchial infusion of adult mesenchymal stem cells|Autologous mesenchymal stem cells derived from bone marrow
116,117,NCT01436058,Osteoarthritis,Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis,mesenchymal stem cell
117,118,NCT01305694,Aplastic Anemia,Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.,bone marrow derived mesenchymal stem cells
118,119,NCT04235296,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Residual Burn Wound,Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound,epidermal growth factor|mesenchymal stem cell conditioned medium-derived pleiotropic factor
119,120,NCT04939077,"Myocardial Ischemia|Ventricular Dysfunction, Left",Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC),Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
120,121,NCT03386708,Uterus; Injury,hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury,intrauterine injection|human umbilical cord mesenchymal stem cell
121,122,NCT02492516,Amyotrophic Lateral Sclerosis,Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS,mesenchymal stem cells
122,123,NCT02057211,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study,autologous mesenchymal stem cell transplantation|sham transplantation of mesenchymal stem cells
123,124,NCT04493918,Spinal Tuberculosis|Mesenchymal Stem Cell,Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection,Mesenchymal Stem cell + Nacl 0.9%|NaCl 0.9%
124,125,NCT03550183,Parkinson's Disease,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease,mesenchymal stem cells
125,126,NCT01895439,Multiple Sclerosis,Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis,Autologous Mesenchymal Stem Cells
126,127,NCT04416139,Covid 19,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,Infusion IV of Mesenchymal Stem cells
127,128,NCT01499459,Liver Cirrhosis,Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis,autologous mesenchymal stem cell transplantation
128,129,NCT04434794,Gingival Recession,Treatment of Gingival Recession Using Mesenchymal Stem Cells,mesenchymal stem cells|standard treatment
129,130,NCT01824069,Nonrevascularizable Critical Ischemia of the Lower Limbs,Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy,Intramuscular injection of a suspension of adult mesenchymal stem cells derived
130,131,NCT02304562,Sweat Gland Diseases,Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair,UCB Mesenchymal Stem Cells treatment
131,132,NCT04184258,Systemic Lupus Erythematosus,Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells,Pooled mesenchymal stem cell|Standard treatment according to the Clinical protocols
132,133,NCT01322789,"Diabetes Mellitus, Insulin-Dependent",Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients,Intravenous Mesenchymal stem cell infusion
133,134,NCT04501354,Osteoporosis,Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients,Mesenchymal Stem Cell
134,135,NCT05075811,"Pouch, Ileal|Fistula",Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease,Ossium vBM-MSC|Placebo
135,136,NCT02287831,Diabetes|Peripheral Arterial Disease,Umbilical Cord Mesenchymal Stem Cells Injection for Diabetes Secondary Peripheral Arterial Disease,umbilical cord mesenchymal stem cells
136,137,NCT01378182,Wilson's Disease,Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis,allogeneic mesenchymal stem cell transplantation
137,138,NCT02235844,Duchenne's Muscular Dystrophy,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),Umbilical Cord Mesenchymal Stem Cells
138,139,NCT05535803,Tracheal Stenosis|Laryngeal Stenosis,Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells|Patients treated according to current clinical protocols
139,140,NCT04444271,COVID-19,Mesenchymal Stem Cell Infusion for COVID-19 Infection,Mesenchymal stem cells|Placebo
140,141,NCT04457037,Trophic Ulcer,Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells
141,142,NCT02731586,Edentulous Alveolar Ridge,Effect on Allogenic Mesenchymal Stem Cells on Osseointegration of Dental Implants,Allogenic Mesenchymal stem cells
142,143,NCT02705742,Liver Cirrhosis,Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis,Mesenchymal Stem Cells
143,144,NCT04432467,Chronic Endometritis|Uterus; Scar|Uterine Synechiae|Fallopian Tube Obstruction,Fertility Restoration Using Autologous Mesenchymal Stem Cells,Autologous mesenchymal stem cells|standard treatment
144,145,NCT03505034,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells
145,146,NCT01392105,Acute Myocardial Infarction,Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction,Mesenchymal stem cell|Control group
146,147,NCT03357770,Knee Osteoarthritis|Umbilical Cord Bleeding,The Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical Cord,mesenchymal stem cells
147,148,NCT05227846,Decompensated Cirrhosis,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1),Human Umbilical Cord-derived Mesenchymal Stem Cells
148,149,NCT02497443,Epilepsy,Safety of Autologous MSC Infusion to Treat Epilepsy,Autologous mesenchymal stem cells
149,150,NCT02283879,Cerebral Hemorrhage,Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela,Human umbilical cord mesenchymal stem cells
150,151,NCT04047810,Chronic Obstructive Pulmonary Disease,Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD),Mesenchymal Stem Cells
151,152,NCT03873506,Bronchopulmonary Dysplasia,Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia,transplantation of hUC-MSCs
152,153,NCT02530047,Ovarian Cancer,Mesenchymal Stem Cells (MSC) for Ovarian Cancer,MSC-INFβ|Questionnaires
153,154,NCT01759784,Amyotrophic Lateral Sclerosis,Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS,Intraventricular injection
154,155,NCT00294112,Crohn's Disease,Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease,Prochymal™ adult human mesenchymal stem cells|adult human mesenchymal stem cells
155,156,NCT04713878,Coronavirus Disease 2019 (COVID-19) Pneumonia,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,Mesenchymal stem cells
156,157,NCT00883870,Critical Limb Ischemia,Mesenchymal Stem Cells in Critical Limb Ischemia,mesenchymal stem cells|Plasmalyte A
157,158,NCT04519684,Ileal Pouch|Crohn Disease,Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease,Mesenchymal stem cells|Placebo
158,159,NCT00850187,Knee Osteoarthritis,Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage,Bone marrow derived mesenchymal stem cells
159,160,NCT03529136,Decompensated Liver Cirrhosis,Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis,UC-MSC
160,161,NCT01459640,Osteoarthritis,Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis,Hyaluronic Acid|Autologous bone marrow-derived mesenchymal stem cells
161,162,NCT01895413,Osteoarthritis,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair,Bone marrow aspiration
162,163,NCT02291926,Cartilage Diseases|Osteoarthritis,Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect,Human umbilical cord mesenchymal stem cells
163,164,NCT04366323,Sars-CoV2,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
164,165,NCT03878628,Dry Eye|Kerato Conjunctivitis Sicca|Aqueous Tear Deficiency,Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease,Adipose tissue-derived mesenchymal stem cells
165,166,NCT00813267,Osteochondritis of the Femoral Head,Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head,mesenchymal stem cell infusion|bone marrow mononuclear cell infusion
166,167,NCT01849887,Ischemic Stroke,Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke,bone marrow-derived mesenchymal stem cells|Placebo
167,168,NCT04357600,Liver Cirrhoses,Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B,Allogeneic Umbilical Cord Mesenchymal Stem Cell
168,169,NCT03180450,Heart Failure,The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|conventional treatment
169,170,NCT05167721,Multiple System Atrophy,Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy,Autologous Mesenchymal Stem Cells|Placebo
170,171,NCT02987413,Motor Neuron Disease,Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients,Autologous Mesenchymal stem cells (MSCs)
171,172,NCT04650568,Anterior Cruciate Ligament Injury|Anterior Cruciate Ligament Rupture,Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction,Autologous Bone Marrow Derived Mesenchymal Stem Cells|Sham incision
172,173,NCT04216849,Type 2 Diabetes With Renal Manifestations,Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy,human umbilical cord mesenchymal stem cells|saline
173,174,NCT03378414,Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 6,Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia,Intravenous infusion|Intrathecal injection|umbilical cord mesenchymal stem cell
174,175,NCT00646724,Type 1 Diabetes Mellitus,Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients,cotransplantation of islet and mesenchymal stem cell
175,176,NCT02239393,Multiple Sclerosis,Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study,Mesenchymal Stem Cells
176,177,NCT01649687,Cerebellar Ataxia,Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells,Allogeneic adult adipose-derived mesenchymal stem cells
177,178,NCT03826433,Hepatitis B,hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis,Peripheral iv
178,179,NCT03362424,Rotator Cuff Tear|Tendon Injuries|Mesenchymal Stem Cell,Mesenchymal Stem Cells in Rotator Cuff Repair,Mesenchymal stem cell|Rotator cuff repair
179,180,NCT03176498,Cerebral Infarction,Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.,Allogeneic umbilical cord mesenchymal stem cell|Aspirin Enteric-coated Tablets & Atorvastatin Calcium
180,181,NCT04661644,Critical Limb Ischemia,Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia,Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial)|Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial)
181,182,NCT01856140,Lateral Epicondylitis,Treatment of Tendon Injury Using Mesenchymal Stem Cells,ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
182,183,NCT04426643,Urinary Incontinence,Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols
183,184,NCT04014166,Thrombocytopenia|Mesenchymal Stem Cells,Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
184,185,NCT03299413,Inflammatory Bowel Diseases,Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease,Wharton Jelly Mesenchymal stem cells
185,186,NCT04382547,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols
186,187,NCT03321942,Mesenchymal Stem Cells|Chronic Kidney Diseases|Renal Interstitial Fibrosis,Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells,Treatment group|Control group
187,188,NCT00962923,Systemic Sclerosis|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc),Allogeneic Mesenchymal Stem Cells (AlloMSC)
188,189,NCT04456361,"ARDS, Human|Covid-19",Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords
189,190,NCT04130100,Knee Osteoarthritis,Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis,Low Dose of Mesenchymal stem cell|High Dose of Mesenchymal stem cell|Sodium Hyaluronate
190,191,NCT02481440,Spinal Cord Injuries,Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI,human umbilical cord mesenchymal stem cells (hUC-MSCs)
191,192,NCT03164083,Osteoarthritis,The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis,Mesenchymal stem cell|Placebo
192,193,NCT04464213,Diabetic Foot Ulcer,Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer,Single dose experiments|Multi-dose experiments
193,194,NCT00972660,Graft Versus Host Disease,Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease,Mesenchymal stem cell (MSC)|Prednisone and cyclosporine or primary therapies
194,195,NCT02790762,Pneumoconiosis,Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis,Human umbilical cord mesenchymal stem cells
195,196,NCT05345418,Sexual Dysfunction Male,Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency,Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency
196,197,NCT04992832,"Heart Failure, Systolic",Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）,human umbilical cord mesenchymal stem cells|human serum albumin
197,198,NCT02652351,Hepatic Cirrhosis,Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis,Human umbilical cord mesenchymal stem cells
198,199,NCT04326985,"Osteoarthritis, Knee",RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):,Autologous Mesenchymal Stem Cells Treatment (MSCs)|Hyaluronic acid (HA)
199,200,NCT04390152,Acute Respiratory Distress Syndrome,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,"Wharton's jelly derived Mesenchymal stem cells.|Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)"
200,201,NCT01985633,"Osteoarthritis, Knee",Mesenchymal Stem Cells Enhanced With PRP Versus PRP In OA Knee,Mesenchymal stem cell suspension|PRP
201,202,NCT03239535,Critical Limb Ischemia,Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy,Mesenchymal stem cells|Normal saline
202,203,NCT04996966,Ischemic Heart Disease|Lung Injury|Non-cardiac Surgery,Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury,human umbilical cord-derived mesenchymal stem cells|saline
203,204,NCT04538885,MSCs-PFs in Treating Poorly Healed Wounds of Postoperative Incision,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision,The pleiotropic factor derived from mesenchymal stem cells
204,205,NCT03209986,Liver Cirrhosis,Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis,mesenchymal stem cell transplantation via peripheral vein|mesenchymal stem cell
205,206,NCT02633163,Systemic Lupus Erythematosus,Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE),Low Dose Mesenchymal Stem Cells (MSCs)|High Dose Mesenchymal Stem Cells (MSCs)|Placebo Infusion
206,207,NCT03979898,Cerebral Palsy,Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP,ASTROSTEM
207,208,NCT05331872,Liver Cirrhosis,Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis,Human umbilical cord-derived mesenchymal stem cell infusion
208,209,NCT05039411,Perianal Fistula Due to Crohn's Disease|Fistula in Ano,Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease,Human umbilical cord mesenchymal stem cells (UC-MSCs)
209,210,NCT05520125,Segmental Fracture - Bone Loss,Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles,Mesenchymal stem cells enriched by extracellular vesicles|Standard treatment of bone defects
210,211,NCT05520112,Recurrent Pregnancy Loss,Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells,Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction|Standard treatment according to the clinical protocols
211,212,NCT03333681,Rheumatoid Arthritis,Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients,Autologous mesenchymal stem cells
212,213,NCT01809769,Knee Osteoarthritis,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis,Mesenchymal stem cells low-dose group|Mesenchymal stem cells mid-dose group|Mesenchymal stem cells high-dose group
213,214,NCT01364246,Progressive Multiple Sclerosis|Neuromyelitis Optica.,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica,human umbilical cord mesenchymal stem cells
214,215,NCT03929120,Interstitial Lung Disease|Connective Tissue Diseases,Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD),Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)
215,216,NCT03580291,Lupus Nephritis,Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN),Mesenchymal stem cells|Mycophenolate Mofetil|Placebo of Mesenchymal stem cells|Placebo of Mycophenolate Mofetil
216,217,NCT02443961,Bronchopulmonary Dysplasia,Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies,Mesenchymal Stem Cell (MSC) therapy
217,218,NCT01456819,Critical Limb Ischemia,Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia,Mononuclear and mesenchymal stem cells|Mononuclear cells
218,219,NCT02668068,Pneumoconiosis,A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells,large volume whole-lung lavage (WLL)|clinical grade umbilical cord mesenchymal stem cells
219,220,NCT01745744,Critical Limb Ischemia,Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.,Mesenchymal stem cells from adipose tissue
220,221,NCT01461720,Middle Cerebral Artery Infarction,Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct,Standard medical care|Autologous bone marrow-derived mesenchymal stem cells
221,222,NCT02749448,Pulmonary Disease,Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients,mesenchymal stem cell
222,223,NCT02477540,Critical Limb Ischemia,A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia,Cellgram-CLI
223,224,NCT00911365,Multiple System Atrophy,Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy,autologous mesenchymal stem cells|normal saline
224,225,NCT02152657,Spinal Cord Injury,Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study,Mesenchymal stem cell transplantation
225,226,NCT05127122,"ARDS, Human",Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles|Saline
226,227,NCT04522869,Primary Biliary Cirrhosis,Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia,Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation
227,228,NCT05522569,"Acute Ischemic Stroke|Mesenchymal Stem Cells|Stroke, Acute|Stroke/Brain Attack|Stroke, Ischemic",Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND),Allogeneic human mesenchymal stem cells (Allo-hMSCs)
228,229,NCT04594850,Erectile Dysfunction,Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously,Cellgram-ED
229,230,NCT01609283,Amyotrophic Lateral Sclerosis,A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis,autologous mesenchymal stem cells
230,231,NCT02945449,Erectile Dysfunction Associated With Type 2 Diabetes Mellitus,Safety of Wharton Jelly in Erectile Dysfunction,Wharton Jelly Mesenchymal stem cells
231,232,NCT03288571,Diabetic Nephropathies,Use of Wharton Jelly in Diabetic Nephropathy,Wharton Jelly Mesenchymal stem cells
232,233,NCT04055415,Pulmonary Hypertension,Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension,adipose derived mesenchymal stem cells|Conventional drug therapy（expectorant，bronchodilator）
233,234,NCT02375568,Knee Injuries,Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application,103024-F
234,235,NCT03562065,Lupus Erythematosus|Stem Cell Transplant,Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord,mesenchymal stem cells
235,236,NCT05122234,COVID-19,Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19,Injection of secretome - mesenchymal stem cell|Placebo|Standard treatment of Covid-19
236,237,NCT05240430,COVID-19 Acute Respiratory Distress Syndrome,When to Apply to Which Patient in MSC?,"Mesenchymal Stem Cell Antigen-1, Human"
237,238,NCT00875654,Ischemia|Stroke,Intravenous Stem Cells After Ischemic Stroke,Autologous mesenchymal stem cells
238,239,NCT02857010,Acute on Chronic Hepatic Failure,Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure,Allogenic mesenchymal stem cells|Placebo
239,240,NCT01526850,Chronic Graft Versus Host Disease,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease,Biological: mesenchymal stem cell|Cyclosporine and Glucocorticoid
240,241,NCT03371329,Hemorrhagic Stroke|Intracerebral Hemorrhage,Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage,MSC
241,242,NCT04499105,Degenerative Disc Disease|Low Back Pain|Disc Degeneration,Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients,"Mesenchymal Stem Cell + NaCl 0,9% 2ml"
242,243,NCT04432545,Systemic Sclerosis Pulmonary|Pulmonary Hypertension|Pulmonary Fibrosis,Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement,Mesenchymal Stem Cells from Wharton ́s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ́s jelly
243,244,NCT02410239,Cerebral Adrenoleukodystrophy,MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD),Mesenchymal Stem Cells
244,245,NCT03876197,Radiation Toxicity|Xerostomia Due to Radiotherapy|Dry Mouth|Hyposalivation|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Long Term Adverse Effects,Mesenchymal Stem Cells for Radiation-induced Xerostomia,Autologous adipose-derived mesenchymal stem/stromal cells|Placebo
245,246,NCT00781872,Multiple Sclerosis,Mesenchymal Stem Cells for the Treatment of MS,Injection of autologous bone marrow derived mesenchymal stem cells
246,247,NCT05495711,"Infertility, Female",hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility,human umbilical cord mesenchymal stem cell complex collagen|intrauterine injection
247,248,NCT01440309,Primary Biliary Cirrhosis,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis,Biological: mesenchymal stem cell|ursodeoxycholic acid
248,249,NCT03487731,Facetogenic Back Pain|Back Pain,Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain,Allogeneic Human Mesenchymal Stem Cells (hMSCs)|Placebo
249,250,NCT01983709,Prostate Cancer,Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer,Allogeneic Human Mesenchymal Stem Cells
250,251,NCT01257776,Critical Limb Ischemia (CLI)|Diabetes,Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients,Autologous adipose derived mesenchymal stem cells
251,252,NCT02292628,Faecal Incontinence,"Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",Infusion of mesenchymal stem cells from adipose tissue|Infusion of placebo
252,253,NCT04062136,Bronchopulmonary Dysplasia,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia,stem cell transplantation
253,254,NCT04811651,Ischemic Stroke,Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke,Umbilical Cord-derived Mesenchymal Stem Cells|Placebo
254,255,NCT04823000,Multiple Sclerosis,Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis,Mesenchymal Stem Cells (MSC)
255,256,NCT04520373,Spinal Cord Injuries|Paralysis,Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients,"Best Medical Management: Occupational and Physical Therapy|Autologous, Adipose Derived Mesenchymal Stem Cells"
256,257,NCT01720888,Ischemic Dilated Cardiomyopathy,Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy,BM-MSCs
257,258,NCT02580019,Stroke,Umbilical Cord Derived Mesenchymal Stem Cells Treatment in Ischemic Stroke,Human umbilical cord mesenchymal stem cells
258,259,NCT02677350,Crohn's Disease|Fistulizing Crohn's Disease|Stem Cells,AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE),Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)
259,260,NCT04651855,Amyotrophic Lateral Sclerosis,The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS,Mesenchymal stem cells isolated from Wharton's jelly
260,261,NCT01854125,Immune Function in Blood|Liver Function in Blood|Variation of Ascites|Characters of Quality of Life|Child-Pugh Score,Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites,autologous bone marrow mesenchymal stem cells transplantation|autologous bone marrow msenchymal stem cells transplantation
261,262,NCT02883803,Septic Shock,Treatment of Severe Infections With Mesenchymal Stem Cells,Injection of mesenchymal stem cells|Injection of albumin alone
262,263,NCT01222039,Graft Versus Host Disease|Chronic and Expanded Graft Versus Host Disease|Immune System Diseases,Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.,Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.|Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
263,264,NCT01873625,Rheumatoid Arthritis,Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis,mesenchymal cell transplantation|placebo
264,265,NCT05018871,Cerebral Palsy,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP,autologous adipose derived mesenchymal stem cells
265,266,NCT05018793,Spinal Cord Injuries,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intrathecal Injection for SCI,autologous adipose derived mesenchymal stem cells
266,267,NCT04821479,Amyotrophic Lateral Sclerosis,Repeated Mesenchymal Stem Cell Injections in ALS,Mesenchymal stem cells (MSC)
267,268,NCT03171194,System; Lupus Erythematosus,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Low Dose Mesenchymal Stem Cells (MSCs)
268,269,NCT03608592,Acute Respiratory Distress Syndrome,Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDS,umbilical cord derived mesenchymal stem cells (UCMSCs) suspension|normal saline
269,270,NCT03745417,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis,Umbilical cord mesenchymal stem cells
270,271,NCT04615455,"Keratoconjunctivitis Sicca, in Sjogren's Syndrome",Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome,ASCs|Cryostor CS10
271,272,NCT03751735,Erectile Dysfunction Associated With Type 2 Diabetes Mellitus,Efficacy of Wharton Jelly in Erectile Dysfunction,Wharton Jelly Mesenchymal stem cells
272,273,NCT05152160,Graft Vs Host Disease,Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Umbilical Cord Mesenchymal Stem Cell Therapy
273,274,NCT02675556,Treatment Resistant Depression,Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression,Allo-hMSCs|Placebo
274,275,NCT04876326,"Multiple System Atrophy|Parkinsonism|Multiple System Atrophy, Parkinson Variant",Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy,Autologous Adipose Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
275,276,NCT01610440,Duchenne Muscular Dystrophy,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy,human umbilical cord mesenchymal stem cells
276,277,NCT04388761,Ischemia Reperfusion Injury,Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI),Allogeneic adipose derived mesenchymal stem cells
277,278,NCT03521323,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebos
278,279,NCT02403947,Multiple Sclerosis,MEsenchymal StEm Cells for Multiple Sclerosis,Mesenchymal stem cells|Suspension media
279,280,NCT01302015,Buerger's Disease,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease,RNL-Vascostem®
280,281,NCT03521336,Spinal Cord Injury,Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebo
281,282,NCT00836732,Pened Chest Surgery for Programmes Coronary Bypass,Mesenchymal Stem Cells: Alterations in Genome,harvest of a small bone marrow sample
282,283,NCT00813969,Relapsing-Remitting Multiple Sclerosis|Secondary Progressive Multiple Sclerosis|Progressive Relapsing Multiple Sclerosis,Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS,Autologous mesenchymal stem cell transplantation
283,284,NCT01716481,"Stroke, Ischemic",The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study,Mesenchymal stem cell
284,285,NCT04919135,Frailty,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,Umbilical Cord Mesenchymal Stem Cells transplantation|standard frailty treatment and supplementary medication
285,286,NCT02218437,Complications of Organ Transplant Stem Cells Umbilical Cord,Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）,MSC+ATG
286,287,NCT01914887,Ulcerative Colitis,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis,Allogeneic adipose tissue-derived mesenchymal stem cells
287,288,NCT05167552,Allergic Rhinitis|Rhinosinusitis Chronic,Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells|Standard treatment of type Allergic Rhinitis according to the clinical protocols|Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols
288,289,NCT02643823,Rheumatoid Arthritis,Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis,hUC-MSC + DMARDs|DMARDs
289,290,NCT00314483,Graft vs Host Disease,Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease,Mesenchymal Stem Cell Infusion
290,291,NCT00891501,Degenerative Arthritis|Chondral Defects|Osteochondral Defects,The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects,Bone Marrow Aspiration|Bone marrow mesenchymal stem cell implantation
291,292,NCT02330978,Retinal Degeneration|Primary Open-angle Glaucoma,Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.,Intravitreal transplantation of mesenchymal stem cell|Culture and isolation of autologous bone-marrow mesenchymal stem cells
292,293,NCT03869229,Knee Osteoarthritis|Hip Osteoarthritis|Glenohumeral Osteoarthritis|Osteoarthritis,Adipose-derived Mesenchymal Stem Cells in Osteoarthritis,Intra-articular injection of ADMSC
293,294,NCT05011474,Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc,Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3
294,295,NCT01700920,Osteonecrosis of the Femoral Head,"PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells",bone marrow aspirate
295,296,NCT02751125,Bone Atrophy,Reconstruction of Jaw Bone Using Mesenchymal Stem Cells,BCP with autologous mesenchymal stem cells (MSC).
296,297,NCT00603330,Graft-versus-host Disease|Poor Graft Function|Low Donor T-cell Chimerism,Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function,Mesenchymal stem cells
297,298,NCT02068794,Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma,"MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer",Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
298,299,NCT01547091,Rheumatoid Arthritis,Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis,Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)|Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)|UC-MSC+DMARDS
299,300,NCT02277145,Post-radiotherapy Pulmonary Fibrosis,A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells,clinical grade umbilical cord mesenchymal stem cells
300,301,NCT04429763,COVID-19,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,Umbilical cord derived mesenchymal stem cells|Placebo
301,302,NCT03800810,"Osteoarthritis, Knee",Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management,Hyaluronic Acid|Umbilical Cord Mesenchymal Stem Cell|Recombinant Human Somatropin
302,303,NCT05008588,Ischemic Stroke,Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct,Conditioned Medium|Umbilical Cord Mesenchymal Stem Cells|Neurologic and Neutrophic Drugs
303,304,NCT03173638,Non Arteritic Ischemic Optic Neuropathy,Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy,intravitreal injection of MSV
304,305,NCT00476060,Cirrhosis,Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis,Autologous mesenchymal stem cell transplantation
305,306,NCT02625246,Bronchiectasis,Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis,hMSCs
306,307,NCT00420134,Liver Failure|Cirrhosis,Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial,injection of progenitor of hepatocyte drived from Mesenchymal stem cell
307,308,NCT01513694,Intervertebral Disc Disease,Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease,Instrumented posterolateral arthrodesis
308,309,NCT04421274,Myocardial Infarction,Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction,Bone marrow mesenchymal stem cells transfer|Best medical treatment|Percutaneous coronary intervention
309,310,NCT05362786,Chronic Kidney Diseases,Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)|Allogeneic adipose-derived mesenchymal stem cells (MSC)
310,311,NCT01540292,Crohn's Disease,Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders,Mesenchymal Stem Cells (MSC)
311,312,NCT05329662,Sexual Dysfunction Female,Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female,Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
312,313,NCT01413035,Type 2 Diabetes,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes,MSC
313,314,NCT02564328,Stroke,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke,Intravenous stem cell transplantation
314,315,NCT01389661,Maxillary Cyst|Bone Loss of Substance,Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H),MSV treatment
315,316,NCT01586312,"Osteoarthritis, Knee|Arthritis of Knee|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,Allogenic mesenchymal stromal cells injection|Hyaluronic Acid
316,317,NCT02808208,End Stage Renal Disease (ESRD)|Vascular Access Complication,Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure,Single Application of Adipose Derived Mesenchymal Stem Cells (AMSC)|Placebo|Two Applications of Adipose Derived Mesenchymal Stem Cells (AMSC)
317,318,NCT05284604,Frailty,Mesenchymal Stem Cells for Age-Related Frailty,Mesenchymal Stem Cells (MSCs)
318,319,NCT01758055,Emphysema,Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients,Autologous MSCs transplantation
319,320,NCT02462330,Chronic Myocardial Ischemia,Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2),Autologous MSC from bone marrow|Placebo comparator
320,321,NCT01374854,Type 1 Diabetes Mellitus,Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus,Umbilical mesenchymal stem cell (UC-MSCs) infusion|traditional therapy
321,322,NCT04565665,COVID-19 Infection|COVID-19-Associated Acute Respiratory Distress Syndrome|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,Best Practice|Mesenchymal Stem Cell
322,323,NCT01076920,Chronic Myocardial Ischemia|Left Ventricular Dysfunction,Mesenchymal Stem Cells and Myocardial Ischemia,Mesenchymal stem cells
323,324,NCT01643681,Lumbar Intervertebral Disc Degeneration,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration,Autologous Adipose Tissue derived MSCs Transplantation
324,325,NCT01218464,Liver Failure|Mesenchymal Stem Cells,Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure,Conventional plus MSC treatment|Conventional plus pacebo treatment
325,326,NCT04315987,COVID-19 Pneumonia,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,NestaCell®|Placebo
326,327,NCT02223897,Ischemic-type Biliary Lesions,Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions,huc-MSCs|Placebo
327,328,NCT01142856,Amyotrophic Lateral Sclerosis,Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS),autologous mesenchymal stem cells
328,329,NCT04280003,Ischemic Stroke|Adipose Tissue-derived Stem Cell|Functional Status,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke,Alogenic adipose tissue-derived stem cells|Placebo solution
329,330,NCT04228666,Alzheimer Disease,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease,HB-adMSCs
330,331,NCT04314661,"Osteoarthritis, Knee",Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis,Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome|Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome
331,332,NCT05308836,Type 1 Diabetes,Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment,adipose-derived messenchymal stem cell
332,333,NCT04506073,Parkinson's Disease,Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD,MSC+placebo|MSC|Placebo
333,334,NCT04093336,"Infarction, Middle Cerebral Artery|Infarction, Anterior Cerebral Artery|Cerebral Infarction|Stroke, Ischemic|Acute Stroke|Brain Infarction|Infarction, PCA|Infarction, Posterior Circulation, Brain",Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients,human umbilical cord mesenchymal stem cells|Placebo|standardized treatment
334,335,NCT01759797,Amyotrophic Lateral Sclerosis,Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS,intra venous injection of stem cell
335,336,NCT01714167,Stroke,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke,intracerebral stem cell transplantation
336,337,NCT04235868,Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Non-healing Wounds,Stem cell-derived derived pleiotropic factor|fibroblast growth factor
337,338,NCT00395200,Multiple Sclerosis,Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS),MSC Treatment
338,339,NCT02192749,Autism,Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism,Umbilical cord mesenchymal stem cells
339,340,NCT02544802,Osteoarthritis Knee,Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee,Adipose-Derived Mesenchymal Stem Cells
340,341,NCT03279796,Rotator Cuff Tear|Lateral Epicondylitis,Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived MSCs|Compound betamethasone
341,342,NCT02941666,Osteonecrosis,Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip,
342,343,NCT01771640,Amyotrophic Lateral Sclerosis,Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS,intrathecal injection
343,344,NCT04433104,COPD,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,Umbilical Cord Mesenchymal Stem Cells transplantation|drug therapy according to Vietnamese MOHS procedure
344,345,NCT01985464,Rheumatoid Arthritis,Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis,Umbilical cord mesenchymal stem cells
345,346,NCT01429038,Liver Failure|Kidney Failure,Mesenchymal Stem Cells After Renal or Liver Transplantation,Mesenchymal Stem Cells
346,347,NCT02034188,Multiple Sclerosis,Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Umbilical cord mesenchymal stem cells
347,348,NCT04064879,"Chronic Migraine, Headache",The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine,AD-SVF
348,349,NCT04282928,Severe Pneumonia,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian,Human umbilical cord mesenchymal stem cells|Routine treatment
349,350,NCT02957552,Pediatric Liver Transplantation,Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation,Mesenchymal Stem Cells
350,351,NCT00587990,"Stem Cell Transplantation|Ventricular Dysfunction, Left",Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS),Lower dose mesenchymal stem cell (MSC) injection|Placebo|Higher dose MSC injection
351,352,NCT00250302,Tibial Fracture,Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures,autologous mesenchymal stem cells implantation
352,353,NCT03259217,Stem Cell Transplant,Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers,Stem Cell Product
353,354,NCT03798353,Myocardial Infarction,Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue,PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.|Surgery by sternotomy
354,355,NCT04392206,End Stage Renal Disease,AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses,Adipose Derived Mesenchymal Stem Cells
355,356,NCT00823316,Acute Leukemia,Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation,Human umbilical cord blood-derived mesenchymal stem cells|Human umbilical cord blood-derived mesenchymal stem cells
356,357,NCT04312113,Ulcerative Colitis,Angiographic Delivery of AD-MSC for Ulcerative Colitis,"Adipose derived, autologous mesenchymal stem cells"
357,358,NCT03945487,Decompensated Liver Cirrhosis,Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis,umbilical cord-derived mesenchymal stem cell|Comprehensive treatment
358,359,NCT04869761,"Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus|Diabetic Nephropathies",Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion|Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions
359,360,NCT03477942,Musculoskeletal Pain|Knee Osteoarthritis|Cartilage Injury|Cartilage Degeneration,Impact of Mesenchymal Stem Cells in Knee Osteoarthritis,Autologous Mesenchymal Stem Cells
360,361,NCT04224207,Retinitis Pigmentosa|Inherited Retinal Dystrophy,Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells,Wharton's jelly derived mesenchymal stem cell
361,362,NCT01183728,"Osteoarthritis, Knee|Knee Degenerative Disease|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells,Autologous bone marrow mesenchymal stem cells (MSV)
362,363,NCT04326959,Keloid,"Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid",Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium|Conditioned Medium|Triamcinolone Acetonide
363,364,NCT01552707,"Lumbar Spondylolisthesis Involving L4-L5, and/or|Degenerative Discopathy Involving L4-L5",Safety Study of Mesenchymal Stem Cells and Spinal Fusion,XCEL-MT-OSTEO-ALPHA|Standard treatment
364,365,NCT02298023,Rotator Cuff Tear,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear),allogenic adipose stem cell injection|fibrin glue/normal saline injection|normal saline injection
365,366,NCT04898088,COVID-19 Pneumonia,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,Mesenchymal Stem Cells Transplantation
366,367,NCT03673748,Lupus Nephritis|Lupus Erythematosus,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,Mesenchymal stromal cells (MSC)|Placebo
367,368,NCT02981576,Spinal Cord Injuries,Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.,Autologous Mesenchymal Stem Cells
368,369,NCT02881489,Amyotrophic Lateral Sclerosis,Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis,Biological: Cell-based therapy
369,370,NCT00447460,Graft-vs-Host Disease (GVHD),Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell,Mesenchymal stem cell (MSC)
370,371,NCT01549665,Graft-Versus-Host Disease|GVHD|Allogeneic Hematopoietic Transplant|Disorder Related to Transplantation,Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease,Human umbilical cord blood-derived mesenchymal stem cells
371,372,NCT04153630,"Epidermolysis Bullosa Dystrophica, Recessive",Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa,mesenchymal stem cells derived from bone marrow (BM-MSCs)
372,373,NCT02338271,Low Back Pain,Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration,autologous adipose derived mesenchymal stem cell
373,374,NCT01668576,Lung Transplantation,Properties of Mesenchymal Stem Cells in Lung Transplant,
374,375,NCT01092026,Allogeneic Stem Cell Transplantation,Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells,cord blood transplantation
375,376,NCT05262829,Crohn Disease,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease,Human Umbilical Cord Mesenchymal Stem Cells
376,377,NCT03570333,Gingival Recession|Lack of Keratinized Gingiva (Disorder),Progenitor Potential of Mesenchymal Stem Cells in Palatal Tissue Harvested From Molar and Premolar Sites,progenitor potential of Gingival Mesenchymal cells
377,378,NCT02035514,Relapsing Remitting Multiple Sclerosis (RRMS),Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,Bone marrow autologous mesenchymal stem cells transplantation
378,379,NCT05442437,HBV,Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study,hUCMSCs
379,380,NCT01499056,Hip Osteoarthritis,Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint,stem cell injection
380,381,NCT03181087,Uterine Scar,Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,Umbilical cord MSCs
381,382,NCT03308565,Spinal Cord Injuries|Paralysis,Adipose Stem Cells for Traumatic Spinal Cord Injury,"Autologous, Adipose derived Mesenchymal Stem Cells"
382,383,NCT01958502,Nonunion of Fracture,Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold,surgical treatment of non union with mesenchymal stem cells with BMP2 within a 3-D tissue engineered scaffold
383,384,NCT04314011,Aging Frailty,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty,Human umbilical cord mesenchymal stem cells（HUC-MSCs）|Placebo
384,385,NCT03414697,Cerebral Palsy,Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different Routes,Control group|UC-MSCs
385,386,NCT02688049,Spinal Cord Injury,NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair,NeuroRegen scaffold/mesenchymal stem cells transplantation|NeuroRegen scaffold/neural stem cells transplantation
386,387,NCT04543994,Ulcerative Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC),Remestemcel-L|Remestemcel-L|Placebo
387,388,NCT03326505,Multiple Sclerosis,Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment,Umbilical cord derived Mesenchymal Stem Cells|Supervised physical therapy
388,389,NCT02237846,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis,Human umbilical cord tissue-derived mesenchymal stem cells
389,390,NCT00366145,Graft Versus Host Disease,Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD),Prochymal®|Placebo|Standard of Care for GVHD
390,391,NCT02574585,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury,Autologous mesenchymal cells transplantation
391,392,NCT02985346,Idiopathic Pulmonary Hemosiderosis,Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis,Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis
392,393,NCT02855112,"Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]",Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients,Adipose derived mesenchymal stem cell
393,394,NCT03816852,Premature Ovarian Failure,The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency,hucMSCs
394,395,NCT04371601,COVID-19 Pneumonia,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,Oseltamivir|hormones|oxygen therapy|mesenchymal stem cells
395,396,NCT02304588,Diabetic Foot|Lower Limb Ischemia,Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot,Mesenchymal stem cells
396,397,NCT04657458,Covid19|ARDS|Hypoxia|Cytokine Storm,A Global Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment
397,398,NCT02770430,Graft vs Host Disease,Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease,mesenchymal stem cells|conventional treatment
398,399,NCT03361631,"Erectile Dysfunction|Stem Cells|Diabetes Mellitus, Type 1",Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes,Autologous Bone Marrow derived Mesenchymal Stem Cells
399,400,NCT01860417,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),Allogenic Mesenchymal Stromal Cells|Mepivacaine
400,401,NCT05413148,Retinitis Pigmentosa,The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa,Subtenon injection of Wharton jelly derived mesenchymal stem cells|Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes|Placebo
401,402,NCT03874572,Xerostomia Due to Radiotherapy|Hyposalivation|Xerostomia|Oropharynx Cancer|Salivary Gland Diseases|Dry Mouth|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Stem Cells,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,Allogeneic adipose derived stem/stromal cells
402,403,NCT02611167,Parkinson's Disease,Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease,Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)
403,404,NCT03265613,Mesenchymal Stromal Cells|Psoriasis|Drug Toxicity|Drug Effect,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,adipose-derived multipotent mesenchymal stem cells
404,405,NCT02034786,Lipodystrophies|Aesthetics Procedure,Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid,Adipose tissue collection|Transdermal injection|Transdermal injection
405,406,NCT04314687,Cerebral Palsy,Stem Cell and Conditioned Medium for Cerebral Palsy,Umbilical Cord Mesenchymal Stem Cells|Conditioned Medium|Standard Therapy
406,407,NCT01207869,Bronchopulmonary Dysplasia|Extremely Premature Infants|Severe BPD That Conventional Therapies Has Failed|No Severe Congenital Anomalies|no Severe IVH Neither Cystic PVL,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia,ucMSCs|Normal saline
407,408,NCT04548583,Crohn Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis,Remestemcel-L|Remestemcel-L|Placebo
408,409,NCT02108132,Hemophilia,Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia,Cellular therapy|cellular therapy
409,410,NCT01162915,Spinal Cord Injury,Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury,Autologous bone marrow-derived mesenchymal stem cells.
410,411,NCT03458156,Lupus Nephritis,Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis,SLE group|LN group|the control group
411,412,NCT04592640,Chronic Kidney Diseases|Calciphylaxis|Calcific Uremic Arteriolopathy|Treatment,Stem Cells for Uremic Calciphylaxis Patients,Human amniotic mesenchymal stem cells
412,413,NCT02594839,Idiopathic Interstitial Pneumonia|Interstitial Lung Disease|Idiopathic Pulmonary Fibrosis,Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease,Bone marrow mesenchymal stem cells|Placebo
413,414,NCT05016011,"Osteoarthritis, Knee",Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)|Marrow cellution
414,415,NCT02315027,MSA,Mesenchymal Stem Cell Therapy in Multiple System Atrophy,Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells
415,416,NCT04602104,Acute Respiratory Distress Syndrome,A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS,low dose hMSC-Exos|medium dose hMSC-Exos|high dose hMSC-Exos|Dosage 1of hMSC-Exos|Dosage 2 of hMSC-Exos|No hMSC-derived exosomes
416,417,NCT02307435,Non Union Fracture|Metaphyseal Fibrous Defect,Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture,MSC
417,418,NCT02833792,Alzheimer Dementia,Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease,Human Mesenchymal Stem Cells and Lactated Riunger's Solution|Placebo
418,419,NCT03237442,Ocular Corneal Burn,Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn,human umbilical cord mesenchymal stem cells|placebo
419,420,NCT02893306,Type 1 Diabetes Mellitus,MSC Administration for the Management of Type 1 Diabetic Patients,MSCs
420,421,NCT03692221,Disc Degeneration,Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease,MSC Treatment group 1 (low dose)|MSC Treatment group 2 (high dose)|Healthy Control (no treatment)
421,422,NCT01724398,Liver Failure,Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure,Conventional plus UC-MSC treatment|Conventional plus PE treatment|Conventional plus UC-MSC and PE therapy|Conventional treatment
422,423,NCT00114452,Myocardial Infarction,Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction,Provacel|Placebo
423,424,NCT03044119,Dental Implants,The Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability,Dental Implant with PRFM|Dental Implant with PRFM and PBMSCs
424,425,NCT01322906,Liver Failure,Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus (HBV),Group 1|Group 2|Group 3
425,426,NCT04146519,Transplantation:Mesenchymal Stem Cell Transplantation,Parkinson's Disease Therapy Using Cell Technology,Autologous mesenchymal stem cells|Placebo
426,427,NCT05319106,Venous Leg Ulcer,Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg,stem cell preparation combined with silver ion dressing|silver ion dressing
427,428,NCT01213953,Lower Back Pain|Disc Degeneration,Isolation and Authentication of Mesenchymal Stem Cell-like Progenitor Cells From the Degenerated Intervertebral Disc of Lumbar Spine,
428,429,NCT01323894,Primary Disease,Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling,
429,430,NCT04692376,Chronic Graft-versus-host Disease,MSC for Treatment of cGVHD After Allo-HSCT,Mesenchymal stem cells|Glucocorticoids|cyclosporine
430,431,NCT04654286,Brachial Plexus Neuropathies,Human Amniotic Membrane and Mesenchymal Stem Cells Composite,Nerve transfer procedure|Nerve transfer with HAM-AdMSC composite wrapping
431,432,NCT05187936,Hemophilia A|Hemophilia B|Arthropathy,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,
432,433,NCT03137979,Periodontitis,Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis,GMSCs and collagen scaffolds|Collagen scaffolds|Open flap debridement
433,434,NCT02408432,Cardiomyopathy|Heart Failure,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,Laboratory Biomarker Analysis|Standard of Care|Mesenchymal Stem Cell Transplantation
434,435,NCT05499156,Perianal Fistula in Patients With Crohn's Disease,Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients,placenal MSC derived exosomes
435,436,NCT03955497,Knee Osteoarthritis|Cartilage Degeneration,Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury,Autologous Adipose-derived Mesenchymal Stem Cell Gel|Sodium Hyaluronate|Extraction of abdominal fat
436,437,NCT03648463,"Cartilage Degeneration|Rotator Cuff Tear|Osteoarthritis, Knee",Use of MRI Labeling Technique to Track Mesenchymal Stem Cell Survival in Orthopaedic Conditions,arthroscopy of the affected knee/ Bone Marrow Concentrate Injection
437,438,NCT03437759,Macular Holes,MSC-Exos Promote Healing of MHs,exosomes derived from mesenchymal stem cells (MSC-Exo)
438,439,NCT03265808,Major Depressive Disorder|Alcohol Use Disorder,Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.,allogeneic human mesenchymal stem cells (allo-hMSCs)|Placebo
439,440,NCT02065245,Frailty,AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery,Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)|Placebo|Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)
440,441,NCT03102879,Periapical Periodontitis,Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.,Regenerative Endodontic Procedure|Conventional Root Canal Treatment
441,442,NCT00136903,Graft Vs Host Disease,Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD),Prochymal® - 2 Million cells/kg|Prochymal®- 8 Million cells/kg|Methylprednisolone|Prednisone|Cyclosporine|Tacrolimus|Mycophenolate Mofetil
442,443,NCT02776943,Cartilage Damage|Degenerative Osteoarthritis,UCMSC Transplantation in the Treatment of Cartilage Damage,umbilical cord mesenchymal stem cells|Hyaluronic acid
443,444,NCT01725698,Union,"The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect","Mesenchymal stem cell, HA-CaSO4, ¬BMP-2, and Implant"
444,445,NCT02685098,Ischemia|Peripheral Arterial Disease|Peripheral Vascular Disease|Vascular Disease|Arterial Occlusive Disease|Arteriosclerosis|Atherosclerosis|Cardiovascular Disease|Pathologic Processes|Orthopedic Procedures|Amputation,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Allogeneic bone marrow derived mesenchymal stem cells
445,446,NCT03840343,"Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency",Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
446,447,NCT02854579,Hypoxic-Ischemic Encephalopathy,Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy,neural progenitor cell|Paracrine factors|progenitor cell and paracrine factors
447,448,NCT01385644,Idiopathic Pulmonary Fibrosis,A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis,Placental MSC
448,449,NCT03070275,Implant Therapy,Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs),Biocomplex: aBM-MSCs/fibrin glue/collagen fleece|Two-stage surgical implant placement
449,450,NCT03552848,Multiple Organ Dysfunction Syndrome,Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection,MSC
450,451,NCT03449082,Lateral Epicondylitis,Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC),High concentration of Allo-ASC|Low concentration of Allo-ASC|Fibrin glue|Normal saline
451,452,NCT03484741,Type 1 Diabetes Mellitus,Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients,MSC and PRP
452,453,NCT04971980,Rheumatoid Arthritis,Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis,hUC-MSC infusion (BC-U001)
453,454,NCT01207661,Osteoarthritis,Articular Cartilage Resurfacing With Mesenchymal Stem Cells In Osteoarthritis Of Knee Joint,Mesenchymal Injection
454,455,NCT01751282,Non Healing Wounds,Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds,Stem Cell
455,456,NCT03166865,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Umbilical-cord mesenchymal stromal cells (UC-MSCs)|Hyaluronic acid
456,457,NCT01769872,Spinal Cord Injury,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury,Autologous Adipose Tissue derived MSCs Transplantation
457,458,NCT01643655,Avascular Necrosis of the Femoral Head,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head,Autologous Adipose Tissue derived MSCs Transplantation
458,459,NCT01874015,Crohn's Disease,Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease,mesenchymal cell transplantation|mesenchymal cell and fibroblast injection
459,460,NCT02208713,Dystrophy,Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD),Intramuscular injection
460,461,NCT00955669,Autologous Transplantation|Diabetic Foot,Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer,Symptoms and Objective Examination
461,462,NCT03609905,Ulcerative Colitis (UC),Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis,Adipose-cord mesenchymal stromal cells (A-MSCs)|Conventional drugs
462,463,NCT02384499,Fecal Incontinence,"Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",ALLO-ASC injection|Placebo
463,464,NCT05078385,Burns,Safety of Mesenchymal Stem Cell Extracellular Vesicles (BM-MSC-EVs) for the Treatment of Burn Wounds,AGLE-102
464,465,NCT04061746,"Diabetes Mellitus, Type 1",Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Mesenchymal Stem Cells (MSCs)|Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
465,466,NCT05152290,Spinal Cord Injuries,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI,AlloRx
466,467,NCT01342250,Liver Cirrhosis,Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis,conventional therapy plus low dose hUC-MSCs treatment|conventional therapy plus medium dose hUC-MSCs treatment|conventional therapy plus high dose hUC-MSCs treatment
467,468,NCT05158127,Skin Ulcer,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer,AlloRx
468,469,NCT03969680,Knee Osteoarthritis,Mesenchymal Stem Cell Transplantation for Osteoarthritis,Auotologous BMSCs plus autologous PRP|Auotologous PRP
469,470,NCT05147675,Osteoarthritis|Spinal Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA,AlloRx
470,471,NCT04484402,Corneal Ulcer|Corneal Disease|Corneal Dystrophy,Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells,mesenchymal stem cells|limbal stem cells|standard treatment
471,472,NCT03384433,Cerebrovascular Disorders,Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke,exosome
472,473,NCT05147701,Eye Diseases|Retinitis Pigmentosa|Glaucoma|Diabetic Retinopathy|Macular Degeneration|Traumatic Optic Neuropathy|Optic Atrophy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases,AlloRx
473,474,NCT05158933,Ovarian Failure,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure,AlloRx
474,475,NCT01605383,Avascular Necrosis of Femur Head,Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head,XCEL-MT-OSTEO-ALPHA|Standard treatment
475,476,NCT05158101,Stroke,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke,AlloRx
476,477,NCT05003960,Autism,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism,AlloRx
477,478,NCT05158439,Tourette Syndrome,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome,AlloRx
478,479,NCT05018858,Lupus,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus,AlloRx
479,480,NCT05003908,Diabetes,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes,AlloRx
480,481,NCT05147766,Congestive Heart Failure|Angina,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease,AlloRx
481,482,NCT05152394,Parkinson Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease,AlloRx
482,483,NCT04642911,Diabete Type 2|Mesenchymal Stem Cell,Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy,Long term follow up
483,484,NCT05018819,Cerebral Palsy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP,AlloRx
484,485,NCT05152381,Osteoporosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis,AlloRx
485,486,NCT05003388,Multiple Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS,AlloRx
486,487,NCT05018832,Traumatic Brain Injury,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI,AlloRx
487,488,NCT05147688,Pulmonary Disease|Asthma|Chronic Obstructive Pulmonary Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases,AlloRx
488,489,NCT05018767,Frailty,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty,AlloRx
489,490,NCT05016804,Systemic Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis,AlloRx
490,491,NCT05018845,Chronic Kidney Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD,AlloRx
491,492,NCT05016817,Idiopathic Pulmonary Fibrosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF,AlloRx
492,493,NCT05003947,Inflammatory Bowel Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD,AlloRx
493,494,NCT05003921,Amyotrophic Lateral Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS,AlloRx
494,495,NCT04855955,Alzheimer Disease,Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease,Adipose-Derived Mesenchymal Stem Cells
495,496,NCT05003934,Rheumatoid Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA,AlloRx
496,497,NCT01291329,ST-Elevation Myocardial Infarction,Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI),intracoronary human umbilical WJ-MSC transfer
497,498,NCT05158114,Testicular Injury|Oligospermia,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia,AlloRx
498,499,NCT04625738,COVID19 ARDS,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|Placebo
499,500,NCT05093725,Umbilical Cord of Normal Labor,CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage,flow cytomery
500,501,NCT04346368,Coronavirus Disease 2019 (COVID-19),Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),BM-MSCs|Placebo
501,502,NCT01274975,Spinal Cord Injury,Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.,Autologous Adipose Derived Mesenchymal Stem Cells
502,503,NCT03392311,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Calcipotriol ointment|adipose-derived multipotent mesenchymal stem cells
503,504,NCT05531266,aGVHD,Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease,hUC-MSCs|glucocorticoids
504,505,NCT01300598,Degenerative Arthritis,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis,Autologous Adipose Tissue derived MSCs Transplantation
505,506,NCT01759212,Heart Failure|Ischemic Cardiomyopathy,Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.,Allogeneic stem cells implantation
506,507,NCT04313647,Healthy,A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers,1X level of MSCs-Exo|2X level of MSCs-Exo|4X level of MSCs-Exo|6X level of MSCs-Exo|8X level of MSCs-Exo
507,508,NCT04385056,Bradykinesia,Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia,MSCTC-0010
508,509,NCT04104451,Diabetic Foot Ulcer,"PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS",Corlicyte
509,510,NCT04288102,Corona Virus Disease 2019(COVID-19),Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),UC-MSCs|Saline containing 1% Human serum albumin（solution without UC-MSCs）
510,511,NCT01728727,Liver Cirrhosis|End Stage Liver Disease,Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis,UC-MSC transplantation|conventional treatment
511,512,NCT01739777,Dilated Cardiomyopathy,Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy,ucMSC|Controls
512,513,NCT01624779,Spinal Cord Injury,Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury,autologous adipose tissue derived mesenchymal stem cells
513,514,NCT02968459,Uterine Scar,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,Umbilical cord MSCs|0.9% Saline
514,515,NCT05042206,Chronic Kidney Disease Stage 3B|Chronic Kidney Disease stage4,Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease,Cellgram-CKD
515,516,NCT01954147,Type 2 Diabetes,Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus,GLP-1|SC|Standard Medical Treatment
516,517,NCT01591200,Alcoholic Liver Cirrhosis,Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells
517,518,NCT02490020,Disorder Related to Renal Transplantation|Renal Transplant Rejection,A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death,mesenchymal stem cell
518,519,NCT01484574,Critical Limb Ischemia|Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells
519,520,NCT01233102,Liver Cirrhosis,Mesenchymal Stem Cells Treat Liver Cirrhosis,Conserved Therapy|Hepatic artery infusion or Intravenous infusion
520,521,NCT04056819,Acute Myocardial Infarction,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction,Allogeneic umbilical cord mesenchymal stem cells
521,522,NCT04219657,Accidental Wound|Heel Injury|Stem Cell Transplant,Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application,mesenchymal stem cell application
522,523,NCT03169231,Aging Frailty,Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Placebo
523,524,NCT01678534,Ischemic Stroke,"Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",Allogenic mesenchymal stem cells from adipose tissue|Placebo
524,525,NCT03726255,Perianal Fistula,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,Mesenchymal Stem Cell injection
525,526,NCT02449005,Chronic Periodontitis,Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects,BM-MSCs/fibrin glue/collagen fleece|Fibrin glue/collagen fleece|Open flap debridement
526,527,NCT04611256,Covid19,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,MSC|Control
527,528,NCT04822922,Acute-On-Chronic Liver Failure,Safety of UC-MSC Transfusion for ACLF Patients,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
528,529,NCT05224960,Decompensated Cirrhosis,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2),UC-MSCs|Placebo(solution without UC-MSCs)
529,530,NCT04212728,Knee Osteoarthritis,Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,Auotologous AMSCs plus autologous PRP|Auotologous PRP
530,531,NCT04064957,Spinal Cord Injuries,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Chronic Spinal Cord Injury,HB-adMSCs
531,532,NCT05121870,Decompensated Cirrhosis,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis,UC-MSCs|Saline containing 1% Human serum albumin（solution without UC-MSCs）
532,533,NCT04453111,Knee Osteoarthritis,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Placenta-derived MMSCs|Bone marrow-derived MMSCs|Hyalgan 20 mg in 2 ML Prefilled Syringe
533,534,NCT02966717,"Renal Insufficiency, Chronic|Nephrotic Syndrome",Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD),Rituximab|conventional therapy|Mesenchymal stem cells
534,535,NCT05402748,Fistula Perianal,Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula,placenta-MSCs derived exosomes
535,536,NCT04551456,Coronary Artery Disease,WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease,Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
536,537,NCT02336646,Critical Limb Ischemia,Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease,Allogenic MSC|Normal saline
537,538,NCT01483248,Liver Cirrhosis|Fibrosis|Liver Disease|Digestive System Disease,Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis,conventional therapy plus MenSC transplantation|Conventional therapy plus placebo treatment
538,539,NCT04087889,Pancreatic Cancer,Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer,HB-adMSCs
539,540,NCT03336996,Characterize and Evaluate Functional After Transplantation|Determine the Therapeutic Efficiency|Correlate the Imaging Results,Assessement the Reconstruction of Motor Circuits in Nerve Fiber Injuries After the Treatment of Umbilical Cord Mesenchymal Stem Cells With Blood Oxygen Level-dependent Drived Diffusion Tensor Imaging,stem cell transplantation|BOLD-fMRI drived DTI scanning
540,541,NCT01453738,Osteoarthritis of Knee,Allogeneic Mesenchymal Stem Cells in Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A
541,542,NCT02286128,Type 2 Diabetes,Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes,
542,543,NCT03967275,Bone Marrow Donor,Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn,bone marrow harvest
543,544,NCT04315025,Retinitis Pigmentosa,Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa,Umbilical Cord Mesenchymal Stem Cell (UC-MSC)|Conditioned Medium (CM)
544,545,NCT01844063,Liver Failure,Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure,Conventional plus BM-MSC treatment|Conventional plus UC-MSC treatment|Conventional treatment
545,546,NCT01690247,Evidence of Liver Transplantation,Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance,Conventional plus UC-MSC|Conventional plus placebo
546,547,NCT00993941,Liver Cirrhosis,Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein,Autologous BMSCs transplantation|Conserved therapy
547,548,NCT02635464,Chronic Ischemic Cardiomyopathy,Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy,hUC-MSCs+Injectable collagen scaffold+CABG|hUC-MSCs+CABG|CABG
548,549,NCT04753476,Covid-19|Cytokine Storm,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,Injection of Secretome-MSCs|Standard treatment of Covid-19
549,550,NCT03003364,"Spinal Cord Injury, Chronic",Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury,XCEL-UMC-BETA|Placebo
550,551,NCT05308342,Premature Ovarian Insufficiency,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency,transplantation of human UC-MSCs into ovaries of POI patients|hormone replacement treatment
551,552,NCT02812121,Liver Failure,UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure,umbilical cord blood mesenchymal stem cells
552,553,NCT03166189,"Infertility, Female|Infertility of Uterine Origin|Asherman Syndrome",Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures,bone marrow-derived MSC and HRT|hormonal replacement therapy
553,554,NCT00752479,Kidney Transplant,Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance,"Mesenchymal stem cells infusion, Basiliximab,Methylprednisolone,RATG ,Cyclosporine ,Mycophenolate mofetil|Basiliximab, Methylprednisolone,RATG,Cyclosporine,Mycophenolate mofetil"
554,555,NCT01531348,Retinitis Pigmentosa,Intravitreal Injection of MSCs in Retinitis Pigmentosa,BM-MSC
555,556,NCT00885729,Defect of Articular Cartilage,Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects,stem cells|Chondrocytes|Rehabilitation program
556,557,NCT03115749,Inflammatory Bowel Diseases,Intestinal Mesenchymal Stem Stells and Inflammatory Bowel Diseases,Intestinal biopsies during colonoscopy|Biopsies taken on surgical specimen
557,558,NCT02395029,Peyronie's Disease,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD,Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs)
558,559,NCT05512988,Chronic Kidney Diseases,Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ),UC-MSC|Saline solution
559,560,NCT02398370,Erectile Dysfunction,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED,Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs)
560,561,NCT02083718,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Hematological Diseases",Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function,PBSC|MSCs
561,562,NCT01144962,Crohn's Disease|Fistula,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,"Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.|Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection."
562,563,NCT05017298,Corona Virus Infection|Covid19,Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells,Allogeneic adipose-derived stem cells
563,564,NCT05507762,Cirrhosis Due to Hepatitis B,Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage),UC-MSCs|Saline solution
564,565,NCT01443689,Burns,Allogenic Stem Cell Therapy in Patients With Acute Burn,human umbilical cord mesenchymal stem cells|human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells|Conventional therapy
565,566,NCT04252118,COVID-19,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,MSCs
566,567,NCT04670302,Supraspinatus Tear,Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation,Tendon repair procedure|Tendon repair augmented with AAdMSC-HAM composite
567,568,NCT03795974,"Cerebral Palsy, Spastic",Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy,MNC|MSC|Control
568,569,NCT03774537,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia,Transplantation of hUC-MSCs|No transplantation of hUC-MSCs
569,570,NCT02439541,Chronic Ischemic Heart Disease|Heart Failure|Angina,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy,UCMSC group
570,571,NCT00698191,Refractory Systemic Lupus Erythematosus,Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE),Allogeneic MSC (AlloMSC)
571,572,NCT02494752,Romberg's Disease|Craniofacial Microsomia|Lipodystrophy|Mixed Connective Tissue Disease,Role of Mesenchymal Stem Cells in Fat Grafting,Fat graft enriched with ex vivo expanded stem cells|Fat graft not enriched with ex vivo expanded stem cells
572,573,NCT02442037,Ulcerative Colitis,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis,UCMSC group|Control group(Normal saline)
573,574,NCT04174898,Aging Well|Regenerative Medicine,MSC Infusion for Anti-aging and Regenerative Therapy,human Mesenchymal Stem Cell (MSC) infusion therapy
574,575,NCT01606215,Multiple Sclerosis,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,Mesenchymal stem cells|Placebo
575,576,NCT03291366,Central Nervous System Injury,Mesenchymal Stem Cells in Central Nervous System injury2017,UCMSCC|conventional treatment
576,577,NCT02368587,Ischemic Cardiomyopathy,Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy,WJMSCs Vs. placebo|Placebo
577,578,NCT02444455,Acute Lung Injury|Acute Respiratory Distress Syndrome,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury,UCMSC group
578,579,NCT02529566,Lumbar Degenerative Disc Disease|Lower Back Pain|Chronic Lower Back Pain,Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine,
579,580,NCT02444858,Paraquat Poisoning|Lung Injury,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury,UCMSC group|Control group(Normal saline)
580,581,NCT02698813,"Senescence Wrinkles, Acne, Pitting Scar",Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid,umbilical cord mesenchymal stem cells and hyaluronic acid|hyaluronic acid
581,582,NCT05501418,COVID-19 Infection,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19,Allogeneic umbilical cord mesenchymal stem cells|Controlled normal saline
582,583,NCT03355365,Multiple Sclerosis,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis,Intrathecal MSC-NP injection|Intrathecal saline injection
583,584,NCT01933802,Multiple Sclerosis,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis,intrathecal administration of autologous MSC-NP
584,585,NCT01913886,Ischemic Cardiomyopathy,Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy,MSCs injection
585,586,NCT05532943,Multiple Sclerosis,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Allogeneic umbilical cord mesenchymal stem cells|Control group
586,587,NCT02013700,Idiopathic Pulmonary Fibrosis (IPF),Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER),Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)|matched placebo
587,588,NCT00851162,Bone Neoplasms,Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions,Trinity multipotent stem cells|Demineralized bone matrix(DBM)
588,589,NCT01142050,Type 2 Diabetes Mellitus,Stem Cell Therapy for Type 2 Diabetes Mellitus,mesenchymal stem cells
589,590,NCT04834609,Perianal Fistula|Adipose Tissue|Tissue Transplantation,Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas,Injection of autologous adipose tissue in anal fistula
590,591,NCT04889963,Adypose Mesenchimal Stem Cell|Ligament Rupture|Ligament Derived Conditined Medium,Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium,adypose mesenchymal conditioned medium and ligament derived conditioned medium
591,592,NCT03933995,Erectile Dysfunction,Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction,no Intervention
592,593,NCT00361049,Cancer,Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant,graft versus host disease prophylaxis/therapy|fluorescence in situ hybridization|immunoenzyme technique|immunohistochemistry staining method|laboratory biomarker analysis|in vitro-treated bone marrow transplantation|management of therapy complications
593,594,NCT02557724,Liver Failure|Liver Neoplasm,Mobilization of Mesenchymal Stem Cells During Liver Transplantation,blood samples|blood samples
594,595,NCT04749667,Multiple Sclerosis|Progressive Multiple Sclerosis,Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis,MSCs|Saline
595,596,NCT04610359,Interstitial Cystitis|Stem Cell Transplant|Mesenchymal Stem Cell,Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis,MR-MC-01
596,597,NCT05116761,Covid19|Postviral Syndrome|Dyspnea,ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles|Saline
597,598,NCT01448434,Osteoarthritis of Knee Joint,Allogeneic Mesenchymal Stem Cells for Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A
598,599,NCT01879046,Knee Osteoarthritis,Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells,arthroplasty
599,600,NCT04276987,Coronavirus,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,MSCs-derived exosomes
600,601,NCT04313322,Use of Stem Cells for COVID-19 Treatment,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,WJ-MSCs
601,602,NCT04366063,Covid-19,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Cell therapy protocol 1|Cell therapy protocol 2
602,603,NCT03047772,"Myocardial Infarction|Stem Cell Transplantation|Angioplasty, Transluminal, Percutaneous Coronary",Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients,Atorvastatin|Intensive Atorvastatin|Low dose BMMSC|Middle dose BMMSC|High dose BMMSC|Transplantation
603,604,NCT01957826,Primary Idiopathic Dilated Cardiomyopathy,Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy,bone marrow-derived MSCs injection|placebo intervention
604,605,NCT01275612,Solid Tumors|Acute Kidney Injury,Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Mesenchymal stromal cell infusion
605,606,NCT02327832,Liver Regeneration,Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs,Autologous BMSCs|bone marrow-derived mesenchymal stem cells
606,607,NCT03397095,Ischemic Heart Disease,Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study,CSWT+BMMSCs|CSWT+Sham operation
607,608,NCT02574572,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury,Autologous mesenchymal cells transplantation
608,609,NCT03866330,Osteoarthritis|Hip Osteoarthritis|Knee Osteoarthritis|Glenohumeral Osteoarthritis,Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis,Intraarticular injection of WJMSC
609,610,NCT02474342,Rotator Cuff Disease,Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease,Autologous Adipose Tissue Derived MSCs Transplantation|Autologous Adipose Tissue Derived MSCs Transplantation|Autologous Adipose Tissue Derived MSCs Transplantation
610,611,NCT03766217,Cleft Lip and Palate,Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair,Mesenchymal stem cells associated with biomaterials|Iliac crest autogenous bone graft
611,612,NCT05106972,Liver Cirrhosis,Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis,UC-MSC infusion
612,613,NCT04349631,COVID-19,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,HB-adMSCs
613,614,NCT02472002,Coronary Disease|Heart Transplant,Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients,Mesenchymal cell therapy
614,615,NCT04457609,COVID|Pulmonary Infection|Sars-CoV2,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,Oseltamivir|Azithromycin|Umbilical Cord Mesenchymal Stem Cells
615,616,NCT02123368,Osteoarthritis,Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells,Hyaluronic acid|10 million Bone marrow mesenchimal stem cells|100 million Bone marrow mesenchimal stem cells
616,617,NCT00658073,Renal Transplant Rejection,Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts,Kidney transplantation with MSCs infusion|kidney transplantation without MSC infusion
617,618,NCT02325843,Chemical Burns,the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn,human bone marrow MSC
618,619,NCT04340609,Acute Myocardial Infarction,Stem Cell in Acute Myocardial Infarction,Mesenchymal Stem Cells
619,620,NCT03994666,Critical Limb Ischemia,Cell Therapy in Critical Limb Ischemia,allogeneic umbilical cord-derived mesenchymal stem cells|Placebo (NaCl)
620,621,NCT02290041,Discordant Immunological Response in HIV Infected Subjects,Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response,Infusion of MSC|Infusion of placebo
621,622,NCT04213248,Dry Eye,Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD,Umbilical Mesenchymal Stem Cells derived Exosomes
622,623,NCT04785027,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,PSORI-CM01 formula|Gu Ben Hua Yu formula|adipose-derived multipotent mesenchymal stem cells
623,624,NCT01182662,Aplastic Anemia,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia,Human umbilical cord-derived MSCs and cyclosporin A|cyclosporin A
624,625,NCT01420432,Ankylosing Spondylitis,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS),Human umbilical cord-derived MSCs
625,626,NCT05261360,"Knee; Injury, Meniscus (Lateral) (Medial)|Meniscus Tear|Meniscus Lesion|Meniscus; Degeneration|Meniscus; Laceration|Meniscus Injury, Tibial|Knee Injuries|Knee Pain Swelling|Arthralgia",Clinical Efficacy of Exosome in Degenerative Meniscal Injury,SF-MSC-EX|SF-MSC
626,627,NCT05080465,Liver Cirrhosis,Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis,Autologous BM MSC
627,628,NCT01129739,Myelodysplastic Syndromes,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes,Human umbilical cord-derived MSCs|cyclosporine A (CsA)
628,629,NCT03187431,Stem Cell Transplant Complications,Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis,autologous bone marrow mesenchymal stem cells
629,630,NCT01840540,Atherosclerotic Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Hypertension,MSC for Occlusive Disease of the Kidney,Arterial infusion of autologous mesenchymal stem cells
630,631,NCT02445547,Crohn Disease,Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease,UC-MSCs by peripheral intravenous infusion|received hormone maintenance therapy
631,632,NCT02587572,Metabolic Disease|Endothelial Dysfunction,Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial,Peripheral Intravenous (IV) infusion of LMSCs
632,633,NCT04336254,COVID-19,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Intravenous saline injection (Placebo)
633,634,NCT05125562,COVID-19,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial,ExoFlo
634,635,NCT04356300,Multiple Organ Failure,Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection,Exosome of MSC
635,636,NCT04744051,Post-Concussion Syndrome,"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion",50 Adipose Derived Stem Cell Infusion|150 Adipose Derived Stem Cell Infusion|300 Adipose Derived Stem Cell Infusion|Placebo Infusion
636,637,NCT03585855,Interventional,Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR),MSC transplantation
637,638,NCT04501341,T2D,BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients,"Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC|Intravenous Infusion of UC-MSC"
638,639,NCT02888704,Atopic Dermatitis,Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis,ADSTEM Inj. (Adult human mesenchymal stem cells)
639,640,NCT01741857,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus,human umbilical cord derived MSC transplantation for SLE
640,641,NCT01494480,Amyotrophic Lateral Sclerosis,The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis,stem cell transplantation
641,642,NCT00976287,Liver Cirrhosis,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis,Hepatic artery infusion|Conserved Therapy
642,643,NCT02055625,Graft -Versus-host-disease,Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease,Mesenchymal stromal cells
643,644,NCT03592849,"Infertility, Female|Endometrium",The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring,UC-MSCs therapy
644,645,NCT03602872,Knee Osteoarthritis,Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis,Human allogeneic mesenchymal bone marrow derived stem cells
645,646,NCT02587715,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy
646,647,NCT02418325,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy
647,648,NCT03798028,Rheumatoid Arthritis,The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis,UC-MSCs
648,649,NCT05210309,"Safety|Efficacy, Self",National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study),Stem Cell Therapy
649,650,NCT05043610,"Myocardial Infarction, Acute|Myocardial Infarction First|Myocardial Infarction, Anterior Wall|Cardiac Remodeling, Ventricular|STEMI|Regenerative Medicine|Heart Failure",MSCs for Prevention of MI-induced HF,Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs)|Conventional Treatment
650,651,NCT04998058,"Bone Loss, Osteoclastic|Bone Loss, Alveolar|Alveolar Bone Loss|Alveolar Bone Atrophy|Grafting Bone",Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting,Maxillary sinus floor elevation grafting with synthetic bone substitute.
651,652,NCT01687777,Chronic Disease,Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair,Mesenchymal Stem Cells (MSCs)|OrthADAPT
652,653,NCT02365142,Knee Osteoarthritis,Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma,100 million Bone marrow mesenchimal stem cells|Platelet Rich plasma (PRGF)
653,654,NCT01489267,Hereditary Cerebellar Ataxia.,A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation,stem cell transplantation
654,655,NCT04490486,COVID-19|Acute Respiratory Distress Syndrome|Corona Virus Infection,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,UCMSCs|Placebo
655,656,NCT03078621,Cerebral Palsy,Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy,Stem Cell Therapy
656,657,NCT03378063,Bronchopulmonary Dysplasia,Stem Cells for Bronchopulmonary Dysplasia,transplantation of mesenchymal stem cell|no transplantation of mesenchymal stem cell
657,658,NCT03460223,Renal Cirrhosis,Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis,MSC
658,659,NCT01143168,Type 1 Diabetes Mellitus,Stem Cell Therapy for Type 1 Diabetes Mellitus,autologous bone marrow mononuclear cells and umbilical cord mesenchymal stem cells
659,660,NCT02961725,Bronchopleural Fistula,Stem Cells for Treatment of Bronchopleural Fistula,UCMSC
660,661,NCT04029896,Cerebral Palsy,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy,HB-adMSCs
661,662,NCT02881476,Amyotrophic Lateral Sclerosis,Therapeutic Treatment of Amyotrophic Lateral Sclerosis,Biological: Cell-based therapy
662,663,NCT03337243,Knee Osteoarthritis|Knee Pain Chronic|Joint Disease|Arthritis|Osteo Arthritis Knee|Musculoskeletal Disease,Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis,HAM and HUMCWJ Injections
663,664,NCT01206179,Nonunion Fractures,Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell,cell injection
664,665,NCT04273646,2019 Novel Coronavirus Pneumonia|COVID-19,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,UC-MSCs|Placebo
665,666,NCT02501811,Ischemic Cardiomyopathy,Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure,Mesenchymal Stem Cells (MSC)|c-kit+ cells|Placebo (Plasmalyte A)
666,667,NCT05018637,Vertebral Compression Fracture|Osteoporotic Fractures,Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture,WJ-MSC|Teriparatide
667,668,NCT04972890,Urologic Diseases|Erectile Dysfunction With Diabetes Mellitus,The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction,stem cells|placebo
668,669,NCT02491658,Psoriasis Vulgaris,Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris,UC-MSCs
669,670,NCT04434768,Acute Stroke,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke,UMSC01
670,671,NCT01045382,"Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute|Leukemia, Myelocytic, Chronic|Myeloproliferative Disorders|Myelodysplastic Syndromes|Multiple Myeloma|Leukemia, Lymphocytic, Chronic|Hodgkin's Disease|Lymphoma, Non-Hodgkin",MSC and HSC Coinfusion in Mismatched Minitransplants,Mesenchymal stem cells|Isotonic solution
671,672,NCT01562002,Limbus Corneae Insufficiency Syndrome,Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome,Stem Cell with Amniotic Membrane Transplant
672,673,NCT04863183,Mesenchymal Stem Cells|Knee Osteoarthritis|Cell Therapy,Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis,CELLISTEM-OA|Triamcinolone acetonide
673,674,NCT04448106,"Osteoarthritis, Knee|Osteoarthritis, Hip|Osteoarthritis Shoulder",Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis,Celltex- AdMSCs
674,675,NCT04652908,Myelomeningocele,Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial,Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix|Untreated contemporaneous cohort
675,676,NCT04909892,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC
676,677,NCT03460795,Liver Cirrhosis,Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease,MSC and Tregs
677,678,NCT03069209,Premature Ovarian Failure,Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF),Stem Cells
678,679,NCT02398604,Hypoplastic Left Heart Syndrome,Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome,Allo-hMSCs|Placebo
679,680,NCT03724617,Thin Endometrium|Intrauterine Adhesion,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium,umbilical cord mesenchymal stem cells combined with collagen scaffold
680,681,NCT02943889,Liver Cirrhosis,Stem Cell Transplantation in Cirrhotic Patients,Mesenchymal stem cell transplantation
681,682,NCT03564808,"Skin Pigmentation Over Contour Deformities of Face|Trauma, Rhomberg Disease","Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for ""Contour Deformities With Pigmentary Changes on Face""",MSC
682,683,NCT02379442,Graft-Versus-Host Disease,Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids,MSC
683,684,NCT00749164,Graft-Versus-Host Disease,Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment,MSC transplantation
684,685,NCT05094011,Idiopathic Parkinson's Disease,"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease",Aadipose-Derived Mesenchymal Stem Cells
685,686,NCT02509156,Cardiomyopathy Due to Anthracyclines,Stem Cell Injection in Cancer Survivors,Allo-MSCs|Placebo
686,687,NCT03058068,Cystic Fibrosis,Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis,Allo-hMSCs|Placebo
687,688,NCT02331134,Malignant Melanoma|Head and Neck Cancer,Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer,Filgrastim
688,689,NCT04063215,Traumatic Brain Injury,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy,HB-adMSCs
689,690,NCT04689152,Alcoholic Cirrhosis,Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis,Cellgram-LC
690,691,NCT03691909,Rheumatoid Arthritis,Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis,HB-adMSCs
691,692,NCT01301664,Mesenchymal Stem Cells,Cartilage Tissue Engineering,total knee / hip replacement
692,693,NCT02241018,Acute Graft-versus-host Disease,MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD,CD25 monoclonal antibody|calcineurin inhibitors|MSCs
693,694,NCT05130983,Crohn Disease|IBD - Irritable Bowel Disease,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease",Bone Marrow MSC Derived Extracellular Vesicle Isolate
694,695,NCT03254758,Decompensated Liver Cirrhosis,A Study of ADR-001 in Patients With Liver Cirrhosis,Mesenchymal stem cell
695,696,NCT00956891,Liver Failure|Mesenchymal Stem Cells,Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation,
696,697,NCT02013674,Chronic Ischemic Left Ventricular Dysfunction|Myocardial Infarction,The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study),Allogeneic hMSCs
697,698,NCT02853942,"Injury of Facial Nerve, Unspecified Side, Initial Encounter",Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm,Autologous adipose stem cell therapy|Mecobalamin
698,699,NCT03014037,Osteoarthritis,Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration,Unilateral Bone Marrow Procurement|Bilateral Bone Marrow Procurement
699,700,NCT02561767,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs in DCD Kidney Transplantation,bone marrow-derived mesenchymal stem cells|Saline|Induction therapy (ATG or Basiliximab)|Maintenance therapy (Low-dose CNI + MPA + steroids)
700,701,NCT03028428,Osteoarthritis|Stem Cells|MSC,Intra-articular Injection of MSCs in Treatment of Knee OA,Placenta Derived Mesenchymal Stem Cell|Sodium Hyaluronate
701,702,NCT02338375,Osteochondral Lesion of Talus,Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product,Cartistem
702,703,NCT03877471,Primary Ovarian Insufficiency,Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency,Cell therapy
703,704,NCT01875081,Alcoholic Liver Cirrhosis,REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient),Livercellgram
704,705,NCT04522986,Severe Acute Respiratory Syndrome Coronavirus 2,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Mesenchymal stem cell
705,706,NCT04905836,Covid19,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,COVI-MSC|Placebo
706,707,NCT04992247,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC|Placebo
707,708,NCT04909879,Acute Respiratory Distress Syndrome|Ards,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,COVI-MSC|Placebo
708,709,NCT04728698,Covid19|ARDS,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo
709,710,NCT03137199,Asthma,Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma,hMSCs
710,711,NCT04289194,Acute Respiratory Distress Syndrome,Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome,HCR040 (Phase 1)|Placebo (Phase 2)|HCR040 (Phase 2)
711,712,NCT03684122,Parkinson Disease,Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).,Injection of Umbilical cord derived MSCs
712,713,NCT03174587,Lupus Nephritis,Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis,allogenic bone marrow derived mesenchymal stem cells
713,714,NCT04466007,Limb Ischemia|Diabetic Foot,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,High dose allogeneic mesenchymal stromal cells|Low dose allogeneic mesenchymal stromal cells|Placebos
714,715,NCT04355728,"Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19",Use of UC-MSCs for COVID-19 Patients,Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Vehicle + Heparin along with best supportive care
715,716,NCT03638154,Periodontal Intrabony Defect,Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis,GF+GMSCs carried on β TCP|β TCP bone substitute only
716,717,NCT01087996,Stem Cell Transplantation,The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study),Auto-hMSCs|Allo-hMSCs
717,718,NCT05095532,Chronic Pancreatitis|Mesenchymal Stem Cells,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT,Bone marrow-derived mesenchymal stem cells|Placebo
718,719,NCT02195323,Chronic Kidney Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Intravenous injection
719,720,NCT02962661,Cardiomyopathy|Heart Failure|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,Best Practice|Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cell Transplantation
720,721,NCT01532076,Osteoporotic Fractures,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts,Cellularized composite graft augmentation|Acellular composite graft augmentation
721,722,NCT01297218,Dementia of the Alzheimer's Type,The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
722,723,NCT00609661,Wound Healing|Burn,Adult Stem Cell Response to Burn Injury,
723,724,NCT04776239,Diabetes Mellitus|Ischemic Heart Disease,Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD),100 million Allogeneic Mesenchymal Human Stem Cells|Placebo
724,725,NCT04953572,Cartilage Injury,Treatment of Cartilage Defects With Peripheral Blood Stem Cells,autologous peripheral blood mesenchymal stem cell|Microfracture|Microfracture + collagen membrane|Autologous osteochondral transplantation
725,726,NCT00498316,Myelodysplastic Syndrome|Leukemia,Cord Blood Expansion on Mesenchymal Stem Cells,Cord Blood Infusion|Busulfan|Fludarabine|Rituximab|ATG|Cyclophosphamide|Clofarabine|Total Body Irradiation (TBI)|Melphalan|Tacrolimus|Mycophenolate Mofetil|G-CSF
726,727,NCT01227694,"Osteoarthritis, Knee|Knee Injuries|Joint Diseases|Rheumatic Diseases|Cartilage Diseases",Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis,Autologous MSC knee implantation
727,728,NCT01652209,Acute Myocardial Infarction,To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.,Hearticellgram-AMI
728,729,NCT01159899,Osteoarthritis|Knee Osteoarthritis|Osteochondritis Dissecans|Osteonecrosis,Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee,Transplantation of Bone Marrow Stem Cells Activated in Knee Arthrosis
729,730,NCT03943940,Type 2 Diabetes Mellitus,BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients,BM-MNC and UC-MSC|Control
730,731,NCT03059355,Endothelial Dysfunction|Metabolic Syndrome|Chronic Inflammation,Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.,UCMSCs|BMMSCs|Placebo
731,732,NCT00543374,Crohn's Disease,Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease,Placebo|PROCHYMAL adult human mesenchymal stem cells
732,733,NCT02064062,"Achilles Tendinitis, Right Leg|Achilles Tendinitis|Achilles Degeneration|Achilles Tendon Thickening|Tendinopathy|Achilles Tendinitis, Left Leg",Autologous Stem Cells in Achilles Tendinopathy,Autologous Mesenchymal Stem Cells
733,734,NCT04573270,Covid19|Prophylaxis,Mesenchymal Stem Cells for the Treatment of COVID-19,PrimePro|Placebo
734,735,NCT03626090,Liver Cirrhosis,Mesenchymal Stem Cell Therapy for Liver Cirrhosis,Autologous BM MSC
735,736,NCT03822858,Multiple Sclerosis,Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis,Intrathecal MSC-NP injection
736,737,NCT04368806,"Osteoarthritis, Knee",A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis,JointStem|Placebo Control
737,738,NCT04348435,COVID-19,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",HB-adMSCs|Placebos
738,739,NCT00883727,Myocardial Infarction,Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI,Stem cell|Plasmalyte A
739,740,NCT01399749,Articular Cartilage Lesion of the Femoral Condyle,Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects,Implantation of autologous cells
740,741,NCT05131412,Pneumonia|Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation,
741,742,NCT00690066,"Type 1 Diabetes Mellitus|Type 1 Diabetes|Diabetes Mellitus, Insulin-Dependent|Juvenile Diabetes",PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM),PROCHYMAL®|Placebo
742,743,NCT02666391,Acute Myocardial Infarction|Myocardial Infarction|Ischemic Cardiomyopathy,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD),umbilical cord mesenchymal stem cells
743,744,NCT04706312,Diminished Ovarian Response,Transplantation of hAMSCs for Woman With DOR,stem cells
744,745,NCT02381366,Bronchopulmonary Dysplasia,Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
745,746,NCT03562715,Preeclampsia,microRNAs Role in Pre-eclampsia Diagnosis,
746,747,NCT04377334,ARDS|COVID-19,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),MSC
747,748,NCT02062931,Premature Ovarian Failure,Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure,Stem Cell Preparation and Injection
748,749,NCT03920397,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation
749,750,NCT04914403,Frailty Syndrome,Mesenchymal Stem Cells for The Treatment of Frailty Syndrome,UMC119-06-05
750,751,NCT03847844,Acute-graft-versus-host Disease,UCMSCs as Front-line Approach of Treatment for Patients With aGVHD,Umbilical cord derived mesenchymal stem cell|Placebo
751,752,NCT02442817,Schizophrenia,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Linagliptin
752,753,NCT03631420,Bronchopulmonary Dysplasia,Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants,Human Umbilical Cord Derived-Mesenchymal Stem Cells
753,754,NCT04476901,Non-ischemic Dilated Cardiomyopathy,Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy,allogeneic human mesenchymal stem cells (hMSCs)|Placebo
754,755,NCT05132972,Covid 19,Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients,Normoxic Allogenic UCMSC|Normal saline solution
755,756,NCT04206007,Chronic Obstructive Pulmonary Disease Moderate,Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease,UMC119-06
756,757,NCT00976430,Parkinson's Disease,Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease,Autologous Bone marrow derived stem cells transplant
757,758,NCT01663376,Critical Limb Ischemia,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia,Autologous Adipose Tissue derived MSCs Transplantation
758,759,NCT03522545,Treatment-resistant Bipolar Depression,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)|Placebo
759,760,NCT05279768,Polycystic Ovary Syndrome,Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.,UC-MSCs|Secretomes|UC-MSCs and Secretomes|Control
760,761,NCT05315661,Frontotemporal Dementia,The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia,ET-STEM
761,762,NCT02848131,Chronic Kidney Disease,Senescence in Chronic Kidney Disease,Group 2: Dasatinib|Group 2: Quercetin
762,763,NCT02003131,Osteoarthritis of the Knee,Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis,Trophic factors from umbilical cord mesenchymal stem cells
763,764,NCT02982915,Aging Frailty,Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Fluzone High Dose Vaccine
764,765,NCT01394432,Acute Myocardial Infarction|Heart Failure,"""ESTIMATION Study"" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction",PCI and Stem Cells or Placebo injections
765,766,NCT01844661,Children|Solid Tumors|Metastases,Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.,CELYVIR
766,767,NCT00827398,Graft-versus-host-disease,Treatment of Steroid Resistant GVHD by Infusion MSC,MSC (hPPL)
767,768,NCT04893174,"Osteoarthritis, Knee",Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).,UMC119-06-05|Hyaluronic acid
768,769,NCT03631589,Steroid-resistant Severe aGVHD,MSC for Severe aGVHD,MSCs
769,770,NCT02192736,Asthma,Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma,Trophic factors from umbilical cord mesenchymal stem cells
770,771,NCT03123458,Immune Related Disorder|Tissue Damage,Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders,clonal fetal MSCs
771,772,NCT02083731,"Stem Cell Transplantation, Hematopoietic|CMV Infection|Hematological Diseases",MSC for Treatment of CMV Infection,MSCs
772,773,NCT01981330,Improved Healing of Scarred Vocal Folds|Improved Vocal Fold Status|Improved Vocal Fold Function,Pilot Study of Stem Cell Treatment of Patients With Vocal Fold Scarring,aMSC|aMSC+hyaluronan gel
773,774,NCT03743155,Xerostomia Due to Radiotherapy,Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy,mesenchymal cells
774,775,NCT02917681,AMYOTROPHIC LATERAL SCLEROSIS,Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis,Two intrathecal MSC injections
775,776,NCT03516006,Primary Sclerosing Cholangitis,Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis,UCMSC|UDCA
776,777,NCT04939337,Crohn's Disease,A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.,TH-SC01
777,778,NCT05333029,Graft Versus Host Disease,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,Allogeneic mesenchymal stromal cells (MSCs)|Extracorporeal photopheresis (ECP)
778,779,NCT02958267,Knee Osteoarthritis,Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee,BMAC injection|PRP injection|Gel-One® hyaluronate injection
779,780,NCT05152368,Peripheral Neuropathy|Trigeminal Neuralgia,Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy,AlloRx
780,781,NCT03925324,Ischemic Heart Disease|Non-ischemic Cardiomyopathy,Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device,Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Placebo
781,782,NCT04339660,COVID-19,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,UC-MSCs|Placebo
782,783,NCT01824121,Progressive Supranuclear Palsy,"Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism",stem cell therapy
783,784,NCT05147779,Erectile Dysfunction|Peyronie's Disease|Interstitial Cystitis,"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",AlloRx
784,785,NCT03158896,Acute Graft Versus Host Disease,Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease,MSCTC-0010 Dose Escalation
785,786,NCT05288725,"Osteoarthritis, Knee",Mesenchymal Stem Cell Therapy for Knee Osteoarthritis,Bone Marrow Derived MSCs|Corticosteroid|Bone Marrow Aspirate
786,787,NCT02237547,Spinal Cord Injury,Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury,Intravenous and intrathecal human umbilical cord tissue-derived mesenchymal stem cells and bone marrow mononuclear cells
787,788,NCT03033277,Primary Ovarian Insufficiency,Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI),Placebo transplantation|HUC-MSCs transplantation
788,789,NCT05167188,Graft Vs Host Disease,Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells,no intervention
789,790,NCT03509025,Knee Osteoarthritis,Follow-up Study for Participants Jointstem Clinical Trial,Jointstem
790,791,NCT01318330,Graft-vs-Host Disease,Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD),Homeo-GH
791,792,NCT00683722,"Pulmonary Disease, Chronic Obstructive|Pulmonary Emphysema|Chronic Bronchitis",PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Prochymal™|Placebo
792,793,NCT02672280,Wounds|Diabetic Foot Ulcers|Burns,Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects,Medical Collagen Membrane with MSC|Medical Collagen Membrane
793,794,NCT04520945,"Osteoarthritis, Knee",Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis,Chondrogen|Placebo
794,795,NCT01742533,Premature Ovarian Failure，,Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure,human umbilical cord mesenchymal stem cells|hUCMSCs and hCBMNCs|human cord blood mononuclear cells|Hormone Replacement Therapy
795,796,NCT05507697,Diabetic Peripheral Neuropathy Type 2,Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy,HUC-MSCs|Lipoic Acid
796,797,NCT02352077,Spinal Cord Injury,NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair,NeuroRegen scaffold with BMMCs or MSCs transplantation
797,798,NCT01454336,Liver Fibrosis,Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone,Cell injection
798,799,NCT05354141,COVID-19 Acute Respiratory Distress Syndrome,Bone Marrow Mesenchymal Stem Cell Derived EVs for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial,EXOFLO
799,800,NCT02809781,"Spondylitis|Spondylitis, Ankylosing|Ankylosis|Arthritis|Spondylarthritis|Spondylarthropathies|Spinal Diseases|Musculoskeletal Diseases|Bone Diseases",A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis,Intravenous infusion of MSCs|Etanercept
800,801,NCT02570932,Spinal Cord Injury,Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries,Autologous Mesenchymal Bone Marrow Cell
801,802,NCT02326935,Multiple Sclerosis,Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis,Autologous adipose derived mesenchymal cells
802,803,NCT01696591,"Alzheimer Disease|Dementia|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Tauopathies|Neurodegenerative Diseases|Delirium, Dementia, Amnestic, Cognitive Disorders|Mental Disorders",The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD,NEUROSTEM®-AD
803,804,NCT04623606,Osteogenesis Imperfecta,Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones,BOOST cells
804,805,NCT00284986,Graft Versus Host Disease,Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients,Prochymal®
805,806,NCT01539902,Lupus Nephritis,Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis,Human Umbilical Cord derived MSCs|Cyclophosphamide
806,807,NCT04776538,Xerostomia Following Radiotherapy,Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients,Stem cells|Placebo
807,808,NCT05176366,Ulcerative Colitis,Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis,ExoFlo
808,809,NCT02210624,Anoxic Brain Injury,Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial,HYNR-CS inj.
809,810,NCT04527224,Covid19 Pneumonia,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,AstroStem-V
810,811,NCT05520086,Chronic Conjunctivitis|Stevens-Johnson Syndrome|Lyell Syndrome|Pemphigoid,Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.,Single Dose|Double Dose
811,812,NCT03887208,Skin|Scar|Cutis Laxa|Keloid|Cicatrix,Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells,Laser therapy|Autologous ADSC injection|Normal saline injection
812,813,NCT00482092,Crohn's Disease,Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease,Prochymal®|Placebo
813,814,NCT03706482,Osteogenesis Imperfecta,Boost Brittle Bones Before Birth,BOOST cells
814,815,NCT02484560,Duchenne Muscular Dystrophy,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell
815,816,NCT03589287,Knee Osteoarthritis,Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis,Chondrochymal®
816,817,NCT05349565,Knee Osteoarthritis,Effects of Muscle Energy Technique in Knee Osteoarthritis Patients,CONVENTIONAL PHYSICAL THERAPY|MUSCLE ENERGY TECHNIQUE
817,818,NCT03799718,"Multiple Sclerosis, Chronic Progressive",Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS,NurOwn (MSC-NTF cells)
818,819,NCT01393977,Spinal Cord Injuries,Difference Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With Spinal Cord Injury in China,rehabilitation of limb function|Stem Cells Transplantation
819,820,NCT03525418,HLHS,Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS),Longeveron Mesenchymal Stem Cells
820,821,NCT01297205,Bronchopulmonary Dysplasia,Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
821,822,NCT04497805,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers,ALLO-ASC-SHEET
822,823,NCT05387278,COVID-19 Acute Respiratory Distress Syndrome|Respiratory Distress Syndrome,Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19),EV-Pure™ and WJ-Pure™|Placebo
823,824,NCT01873547,Spinal Cord Injury,Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China,cell therapy|rehabilitation
824,825,NCT04536233,MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries,Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries,MSCs Derived Pleiotropic Factors|physiological saline
825,826,NCT02923375,Graft vs Host Disease,A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease,Mesenchymoangioblast-derived mesenchymal stem cells
826,827,NCT01719640,"Diabetes Mellitus, Type 2",MSC and BMMNC in Type 2 Diabetes Mellitus,infusion of BMMSCs|infusion BMMNCs|insulin
827,828,NCT02107118,Erectile Dysfunction|Cardiac Disease,Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men,ARM 1: AdMSC: adipose stem cells|ARM 2: Placebo
828,829,NCT03369275,Septic Shock|Sepsis|Pathologic Processes|Shock|Infection|Systemic Inflammatory Response Syndrome|Inflammation,Cellular Immunotherapy for Septic Shock,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|Placebo
829,830,NCT03325504,Non Union Fracture,A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union,Cultured Mesenchymal Stem Cells|Autologous iliac crest graft
830,831,NCT01220492,Liver Cirrhosis,Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis,conventional plus MSC treatment|conventional plus placebo treatment
831,832,NCT03865394,Diabetic Foot Ulcer,Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells,Application of allogeneic ADSC stem cells in fibrin gel|Standard care in diabetic foot ulcer
832,833,NCT02054208,Alzheimer's Disease,Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease,human umbilical cord blood derived mesenchymal stem cells|Normal saline 2mL
833,834,NCT00826046,Graft-Versus-Host Disease,Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD),Prochymal®
834,835,NCT03828344,Rheumatoid Arthritis,Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis,hUC-MSC suspension|Placebo
835,836,NCT00515307,"Hypercholesterolemia, Familial",Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia,Cellular transplantation
836,837,NCT04297813,Alveolar Bone Atrophy,Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting,Advanced medicinal Therapy (MSC combined with biomaterial)|Autologous bone graft
837,838,NCT02513238,Xerostomia,Mesenchymal Stemcells for Radiation Induced Xerostomia,Mesenchymal stem cell|Isotonic NaCl
838,839,NCT03356821,Perinatal Arterial Ischemic Stroke|Neonatal Stroke,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,Mesenchymal Stem Cells
839,840,NCT02789995,Sepsis,Dysfunctions of Human Muscle Stem Cells in Sepsis,Human biological samples
840,841,NCT02290886,Amyotrophic Lateral Sclerosis,A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral,Intravenous administration of placebo|Intravenous administration of 1 million of MSC|Intravenous administration of 2 million of MSC|Intravenous administration of 4 million of MSC
841,842,NCT03325322,Chronic Kidney Diseases|Diabetes Mellitus|Diabetic Nephropathies,Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease,Fisetin|Placebo oral capsule
842,843,NCT01754454,Acute GVH Disease,Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease,Human Umbilical Cord Derived MSC
843,844,NCT03855631,Kabuki Syndrome 1,Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders,Intervention on primary cultured cells
844,845,NCT04551443,Acute Myocardial Infarction,WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction,Intravenous infusion placebo|Intravenous infusion WJMSCs
845,846,NCT05155657,Alcoholic Cirrhosis,Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells,Conventional therapy plus low dose UCMSCs treatment|Conventional therapy plus medium dose UCMSCs treatment|Conventional therapy plus high dose UCMSCs treatment
846,847,NCT02407470,Severe Aplastic Anemia,Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia,Rabbit antithymoglobulin (ATG)|Adipose derived mesenchymal stem cells ( AD-MSCs)|AD-MSC transdifferentiated HSCs (AD-HSCs)
847,848,NCT04288934,Spinal Cord Injuries,Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).,Collection and expansion of BM-MSC|VI-SCI evaluation and patients' follow up
848,849,NCT02815423,Fracture|Bone Nonunion,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion,UCMSCs|Percutaneous
849,850,NCT01849159,Pulmonary Emphysema,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Mesenchymal stem cells|Reference therapy: 400 mL of 0.9% NaCl solution
850,851,NCT05151133,Allergic Rhinitis,Clinical Study of Allergic Rhinitis Therapy by Stem Cells,Low dose UCMSCs|Moderate dose UCMSCs|High dose UCMSCs
851,852,NCT04428801,COVID-19,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,autologous adipose-derived stem cells
852,853,NCT02240992,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Delayed Platelet Engraftment|Hematological Diseases",MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment,PBSC|MSCs
853,854,NCT04657315,"Glioblastoma|Adult Gliosarcoma|Neoplasms, Brain|Neoplasms, Germ Cell and Embryonal|Recurrent Glioblastoma","Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients",MSC11FCD
854,855,NCT04223622,Osteoarthritis,Effects of ASC Secretome on Human Osteochondral Explants,ASC secretome
855,856,NCT04888949,SARS-CoV-2 Infection( COVID-19 ),A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),Mesenchymal stem cell|Placebo
856,857,NCT00877903,Myocardial Infarction,Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI),Prochymal®|Placebo
857,858,NCT04850469,Sepsis|Critical Illness,Study of MSC-Exo on the Therapy for Intensively Ill Children,
858,859,NCT02900014,Cleft Palate,Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate,sampling mesenchymal stem cells
859,860,NCT05279157,Ophthalmological Disorder|Corneal Dystrophy|Treatment|Therapy|Keratoconus,Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD),Implantation|Lipoaspiration
860,861,NCT04275024,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,Calcipotriol ointment|PSORI-CM01 Granule|adipose-derived multipotent mesenchymal stem cells
861,862,NCT02600130,Alzheimer's Disease,Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease,Longeveron Mesenchymal Stem Cells|Placebo
862,863,NCT03818737,Osteoarthritis,Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES),Bone Marrow Derived MSCs|Adipose-derived MSCs|Umbilical Cord Tissue (UCT) MSCs|Corticosteroid injection
863,864,NCT04348461,COVID|Respiratory Distress Syndrome,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells
864,865,NCT03747913,Healthy,Oxidative Stress as an Acute Exercise-induced Mechanism of Stem and Progenitor Cell Mobilization,Antioxidative supplementation
865,866,NCT01626625,Healing of Fracture,Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture,stem cells + hydroxy apatite|autograft taken from iliac crest
866,867,NCT05292625,Ischemic Stroke,Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke,UC-MSC infusion via intravenous route|UC-MSC infusion via intrathecal route|standard stroke treatment and rehabilitation therapy
867,868,NCT04281797,Transplantation Infection|Kidney Transplant; Complications|Stem Cell Transplant Complications|Liver Transplant; Complications|Microbial Colonization,Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients,Intestinal microbiome new generation sequencing
868,869,NCT01409954,Pseudarthrosis After Fusion or Arthrodesis,Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells,
869,870,NCT04243681,"Cirrhosis, Liver",Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis,CD 34 and MSC infusion|Standard of care for Cirrhosis management
870,871,NCT02890953,Cell Transplantation,Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a),Pneumostem|Normal saline
871,872,NCT05508191,Skin Aging|Transepidermal Water Loss,Microneedle Versus Fractional CO₂ Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women,Fractional CO₂ Laser|Microneedle
872,873,NCT03857841,Bronchopulmonary Dysplasia,A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD,UNEX-42|Phosphate-buffered saline
873,874,NCT05027581,"Osteoarthritis, Knee",Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA),Bone marrow mesenchymal stem cells|hyaluronic acid
874,875,NCT03639506,Repetition Failure,Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.,autologous mitochondria transplantation|autologous mitochondria from bone marrow mesenchymal stem cells into oocyte as well as intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (ICSI)
875,876,NCT02334878,"Urinary Incontinence, Stress",Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence,"Stem Cells,Mesenchymal|surgery (TVT)"
876,877,NCT03186417,Rheumatoid Arthritis,Mesenchymal Stem Cells in Early Rheumatoid Arthritis,2 million hMSC/kg|4 million hMSC/kg|6 million hMSC/kg|placebo
877,878,NCT05066334,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD,Autologous BM-MSC|Sham
878,879,NCT03990805,Degenerative Arthritis|Knee Osteoarthritis,A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,JOINTSTEM|saline
879,880,NCT02648386,Rectal Cancer|Erectile Dysfunction,Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery,Laparoscopic surgery|NeuroRegen scaffold transplantation|NeuroRegen scaffold/BMMCs transplantation|NeuroRegen scaffold/HUC-MSCs transplantation
880,881,NCT01496339,Type 1 Diabetes Mellitus,Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients,MenSCs transplantation|exogenous indulin injection daily
881,882,NCT04325594,Chronic Heart Failure|Non-ischemic Cardiomyopathy|Non-ischemic Dilated Cardiomyopathy,The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Chronic Heart Failure of Non-ischemic Etiology,Cardiac catheterization|Intracoronary administration of the umbilical cord-derived mesenchymal stromal cells
882,883,NCT04877067,Methanol Poisoning|Toxic Optic Neuropathy|Stem Cell Tyrosine Kinase 1 Y842X|Magnetic Field Exposure,Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation,Wharton jelly derived mesenchymal stem cell|Repetitive electromagnetic stimulation
883,884,NCT04240873,"Osteoarthritis, Knee",Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis,Catholic MASTER cell|Saline
884,885,NCT01547689,Alzheimer's Disease,Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease,Human Umbilical Cord Derived MSC
885,886,NCT02145897,Critical Limb Ischemia,To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derieved MSCs|Control
886,887,NCT01343511,Autism,Safety and Efficacy of Stem Cell Therapy in Patients With Autism,human cord blood mononuclear cells|human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells
887,888,NCT00759018,Graft vs Host Disease|Graft-Versus-Host Disease,Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD,remestemcel-L
888,889,NCT02563340,Kidney Transplantation,Effect of BM-MSCs on Chronic AMR After Kidney Transplantation,"BM-MSCs|Desensitization therapy (PP, IVIG, rituximab or Bortezomib)"
889,890,NCT03860155,Acute-On-Chronic Liver Failure,Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure,allo-APZ2-ACLF
890,891,NCT03925649,Spinal Cord Injury at C5-C7 Level,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI,HB-adMSCs
891,892,NCT03000712,Degenerative Arthritis|Knee Osteoarthritis,Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.,Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml
892,893,NCT04097652,Acute Ischemic Stroke,Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke,UMC119-06
893,894,NCT04347967,Acute Respiratory Distress Syndrome,Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS),UMC119-06
894,895,NCT04739930,Cartilage Injury,Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation,Autologous bone marrow aspirate will be harvested and concentrated to a bone marrow aspirate concentrate (BMAC) containing bone marrow derived mesenchymal stem cells and delivered to site of operation|Control group incision
895,896,NCT02563366,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.,BM-MSCs|Saline
896,897,NCT04535856,Covid19|Corona Virus Infection|SAR,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,allogeneic mesenchymal stem cell|Placebo
897,898,NCT02672306,Alzheimer's Disease,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease,UCMSCs|Placebo
898,899,NCT02104440,Cytopenia,Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro,"Sequential infusion of allogeneic mesenchymal stem cells expanded ""in vitro"""
899,900,NCT01213186,Human Immunodeficiency Virus|Disorder of Immune Reconstitution,Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients,high dose of MSC|low dose of MSC treatment
900,901,NCT02045745,Postoperative Air Leaks in Risk Patients,"Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells","Implantation of autologous mesenchymal stem cells (CSM) expanded ""in vitro"" and administered directly into the lung suture line"
901,902,NCT02065167,Avascular Necrosis of the Femoral Head,Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip,Cultured autologous Mesenchymal Cells
902,903,NCT03839238,Meniscus Injury,Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury,hESC derived MSC like cell
903,904,NCT01803347,Anal Fistula,Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells,◦Drug: ASCs. + fibrin glue|fibrin glue
904,905,NCT02917291,Acute Traumatic Spinal Cord Injury,Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury,FAB117-HC|Control group|FAB117-HC
905,906,NCT01733186,Degeneration Articular Cartilage Knee,"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects",CARTISTEM®
906,907,NCT01309061,Progressive Hemifacial Atrophy|Romberg's Disease,The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease,Autologous Adipose Tissue derived MSCs Transplantation
907,908,NCT01091701,Stroke,Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke,Ex vivo cultured adult allogenic MSCs|Plasmalyte-A
908,909,NCT01033552,Epidermolysis Bullosa,"Biochemical Correction of Severe EB by Allo HSCT and ""Off-the-shelf"" MSCs",Cyclophosphamide|Fludarabine|Anti-thymocyte globulin|Cyclosporine A|Mycophenolate mofetil|Mesenchymal stem cell transplantation|Total body irradiation|Bone marrow or umbilical cord blood (UCG) stem cell transplantation
909,910,NCT04040348,Alzheimer Disease,Alzheimer's Disease Stem Cells Multiple Infusions,Approximately 100 million cells allogeneic hMSC
910,911,NCT04825730,Degenerative Arthritis|Knee Arthritis,Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy,JOINTSTEM
911,912,NCT02767817,Brain Injury,Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury,Stereotactic Hematoma Evacuation|MSCs Transplantation|Injectable Collagen Scaffold with MSCs Transplantation
912,913,NCT02313415,Infertility|Intrauterine Adhesions,Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells,UC-MSCs therapy
913,914,NCT03902067,Left Ventricular Dysfunction|Acute Myocardial Infarction,UC-MSC Transplantation for Left Ventricular Dysfunction After AMI,UC-MSC|Control Group
914,915,NCT04461925,COVID-19 Pneumonia,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Antibiotics|Hormones|Anticoagulant Therapy|Оxygen therapy
915,916,NCT02669199,MSCs,MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound,MSCs
916,917,NCT04427930,Knee Osteoarthritis,Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial,JOINTSTEM
917,918,NCT02543073,"Lung Diseases, Interstitial|Hematopoietic Stem Cell Transplantation|Bronchiolitis Obliterans",MSC for Treatment of Interstitial Lung Disease After Allo-HSCT,MSCs|AZM|Glucocorticoid
918,919,NCT04388982,Alzheimer Disease,the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease,low dosage MSCs-Exos administrated for nasal drip|mild dosage MSCs-Exos administrated for nasal drip|high dosage MSCs-Exos administrated for nasal drip
919,920,NCT02947191,Chronic Nasal Septum Perforation,Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation,Collagen membrane + HUC-MSCs
920,921,NCT03672825,Cartilage Defect,REcycled CartiLage Auto/Allo IMplantation,REcycled CartiLage Auto/Allo IMplantation
921,922,NCT05491681,"ARDS, Human",AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial,intravenous delivery of allogeneic bone marrow-derived MSCs
922,923,NCT02786017,Decompensated Cirrhosis,Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis,Conventional therapy|Injectable Collagen Scaffold + HUC-MSCs
923,924,NCT04953663,Stroke,Clinical Plan of Ischemic Stroke,it-hMSC
924,925,NCT05407766,Rectal Fistula,Mesenchymal Stem Cells (MSCs) for Perianal Fistula,OSSM-001|Placebo
925,926,NCT01603836,"Spondyloarthrosis, Spondylosis",Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone,bone allogaft with bone marrow concentrate
926,927,NCT03265444,Multiple System Atrophy,Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy,CS10BR05
927,928,NCT02619877,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers,ALLO-ASC-DFU|Standard therapy
928,929,NCT02619851,Burn Injury,A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects,ALLO-ASC-DFU|Conventional Therapy
929,930,NCT05305833,Temporomandibular Joint Disorders|Temporomandibular Disorder|Temporomandibular Joint Osteoarthritis|Temporomandibular Joint Pain|Temporomandibular Joint Effusion,Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease,Stem Cells
930,931,NCT01207193,Bone Cyst,Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation,cell injection
931,932,NCT03633565,Myopathy,Comparative Study of Strategies for Management of Duchenne Myopathy (DM),Sildenafil (Phosphodiesterase inhibitors)|Prednisolone (Steroids)|Mesenchymal stem cell transplantation
932,933,NCT04494386,Covid19|Corona Virus Infection|SARS-CoV Infection|ARDS|Coronavirus,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,Umbilical Cord Lining Stem Cells (ULSC)|Placebo (carrier control)
933,934,NCT04074408,Basal Ganglia Hematoma,Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration,stereotactic surgery|hUMSCs|placebo
934,935,NCT04342325,"Glomerulonephritis , IGA",The Clinical Trial of ADR-001 for IgA Nephropathy,infusion of ADR-001 (Mesenchymal stem cell)
935,936,NCT02641769,Non-obstructive Azoospermia,Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.,Stem Cell Transplantation
936,937,NCT04339504,Knee Osteoarthritis,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial,SMUP-IA-01(low-dose)|SMUP-IA-01(mid-dose)|SMUP-IA-01(high-dose)
937,938,NCT02672267,Myocardial Infarction,A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction,Stem cells|Placebo
938,939,NCT04951882,Acute Lung Injury,Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research,human derived umbilical cord derived mesenchymal stem cells
939,940,NCT02755376,Deficiency of Anterior Cruciate Ligament,Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell,Cartistem(TM)|hyaluronic acid|ACL reconstruction only
940,941,NCT04612465,Crohn's Fistula,Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula,ASC|Fibringlue
941,942,NCT01909154,Spinal Cord Injury,Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia,Mesenchymal stromal cell therapy
942,943,NCT01325103,Spinal Cord Injury,Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury,Stem Cell Transplantation
943,944,NCT04293692,COVID-19,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,UC-MSCs|Placebo
944,945,NCT01210950,Leg Length Inequality,Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation,cell and RPR injection
945,946,NCT02492490,Uremia,Effect of SVF Derived MSC in DCD Renal Transplantation,SVFderived MSC transplantations|Basiliximab
946,947,NCT04170426,Rheumatoid Arthritis,Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis,autologous adipose derived stem cells
947,948,NCT04173650,Dystrophic Epidermolysis Bullosa,MSC EVs in Dystrophic Epidermolysis Bullosa,AGLE 102
948,949,NCT04562025,Diabetic Nephropathy,Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy,UC-MSCs|Placebo
949,950,NCT03766139,Intrabony Periodontal Defect,Regenerative Potential of Supercell Glue and Platelet Rich Fibrin Matrix,SUPERCELL GLUE|PRFM ALONE
950,951,NCT04954534,Alzheimer's Disease,Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®,human umbilical cord blood derived mesenchymal stem cells
951,952,NCT00221130,Adult Periodontitis,Clinical Trials of Regeneration for Periodontal Tissue,surgical operation of cell transplantation
952,953,NCT04763369,Retinitis Pigmentosa (RP),Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP),Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa|Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa
953,954,NCT02801890,Ultra Filtration Failure,Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF),Intravenous injection
954,955,NCT02696876,"Defect of Articular Cartilage|Cartilage Injury|Osteoarthritis, Knee",Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair,Arthroscopic synovial brushing|Microfracture
955,956,NCT03370874,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.,ALLO-ASC-DFU|Vehicle sheet
956,957,NCT02579148,Erectile Dysfunction|Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes,HUCMSC injection|collagen scaffolds/HUCMSC injection
957,958,NCT03754465,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers,ALLO-ASC-DFU|Hydrogel SHEET(Vehicle control)
958,959,NCT03056742,Critical Limb Ischemia Due to Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease,Stempeucel(R)
959,960,NCT01662973,Primary Biliary Cirrhosis,Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis,conventional plus UC-MSC treatment|Conventional plus placebo treatment
960,961,NCT03183726,Diabetic Foot Ulcer,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial,ALLO-ASC-DFU
961,962,NCT03454737,Patellar Tendinopathy,Treatment of Refractory Patellar Tendinopathy With Mesenquimal Trunk Cells. Comparative Study With PRP.,mesenchymal stem cells|Pure platelet-rich plasma
962,963,NCT05216562,SARS-CoV2 Infection,Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients,Exosome-MSC Intravenous injection|Placebo Intravenous Injection|COVID-19 Standard Treatment
963,964,NCT01392625,Non-ischemic Dilated Cardiomyopathy,PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study),Autologous hMSCs|Allogeneic hMSCs
964,965,NCT03183661,Crohn Disease,A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial,ALLO-ASC-CD
965,966,NCT04675970,Primary Ovarian Insufficiency|Premature Ovarian Failure,Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy,Observational
966,967,NCT01041001,Cartilage Injury|Osteoarthritis,Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury,Cartistem|Microfracture treatment
967,968,NCT05344157,"Osteoarthritis, Knee",A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis,XSTEM-OA
968,969,NCT03105284,Mesenchymal Stem Cells,Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction,Liposuction
969,970,NCT01922908,Ischemic Stroke,Mesenchymal Stromal Cells for Ischemic Stroke,MSC Infusion|Placebo Comparator
970,971,NCT01314092,Complex Perianal Fistula,Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula,Autologous cultured adipose derived stem cells(low dose group)|Autologous cultured adipose derived stem cells(high dose group)
971,972,NCT04362189,COVID-19,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,HB-adMSC|Placebo
972,973,NCT02378974,Cerebral Infarction,Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction,Cordstem-ST|Placebo
973,974,NCT04003857,Bronchopulmonary Dysplasia,Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial,PNEUMOSTEM®|normal saline
974,975,NCT01897987,Bronchopulmonary Dysplasia,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial,Pneumostem®|normal saline
975,976,NCT01828957,Bronchopulmonary Dysplasia,Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants,Pneumostem®|Normal Saline
976,977,NCT04738981,Graft Vs Host Disease,Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT,UC-MSC|Anti-CD25 mAb
977,978,NCT03389919,Mesenchymal Stem Cell Transplantation,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,MSC administration (intraosseal)
978,979,NCT04493242,"Covid19|ARDS|Pneumonia, Viral",Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS,DB-001|Intravenous normal saline
979,980,NCT01661842,Autoimmune Hepatitis,Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis,conventional plus UC-MSC treatment|Conventional plus placebo treatment
980,981,NCT02796079,Peripheral Vascular Disease|Ischemia|Diabetic Foot,A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications,mesenchymal stem cells|saline
981,982,NCT04903327,Covid19,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo
982,983,NCT02674399,"Osteoarthritis, Knee",A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,JointStem|Synvisc-One
983,984,NCT03117738,Alzheimer Disease,A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,AstroStem|Placebo-Control
984,985,NCT03424629,Moderate and Severe Plaque Psoriasis,Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis,Low-dose UC-MSCs|High-dose UC-MSCs|Methotrexate
985,986,NCT04482413,Alzheimer Disease,Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,AstroStem|Placebo
986,987,NCT05116540,Multiple Sclerosis,Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis,HB-adMSCs|Placebo
987,988,NCT04037345,Knee Osteoarthritis,Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis,SMUP-IA-01(low-dose)|SMUP-IA-01(mid-dose)|SMUP-IA-01(high-dose)
988,989,NCT01709656,Ankylosing Spondylitis,A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis,"MSC|""celecoxib"", ""Celebrex®"""
989,990,NCT05433298,COVID-19 Pneumonia|COVID-19,Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.,Mesenchymal stem cell|Placebo
990,991,NCT02166021,Multiple Sclerosis (MS),Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis,Mesenchymal stem cells
991,992,NCT05549609,Venous Leg Ulcer,A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers,XSTEM-VLU|Vehicle
992,993,NCT03489564,Pregnancy Related|Physical Activity,Mitochondrial Capacity in Pregnant Women,Active|Sedentary
993,994,NCT04684602,Autoimmune Diseases|Cardiovascular Disorders|Diabetes Complications|Integumentary Disease|Musculoskeletal Disorders|Neurodegenerative Disorders|Neurologic Disorders|Pulmonary Disorders|Sexual Dysfunction|Urologic Disorders|Viral Illness,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,PrimePro™/ PrimeMSK™
994,995,NCT04452097,COVID-19|ARDS|Acute Respiratory Distress Syndrome,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,Human umbilical cord mesenchymal stem cells + best supportive care|Placebo control + best supportive care
995,996,NCT04492501,Covid19|Cytokine Release Syndrome|Critical Illness|ARDS,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,Therapeutic Plasma exchange|Convalescent Plasma|Tocilizumab|Remdesivir|Mesenchymal stem cell therapy
996,997,NCT02023788,Bronchopulmonary Dysplasia|Respiratory Tract Infections|Premature Birth of Newborn,Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study,PNEUMOSTEM
997,998,NCT03678467,Mandible Tumor|Mandibular Injuries|Mandible; Deformity,Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction,EB-CMF
998,999,NCT05283317,Sepsis|Septic Shock,Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock,Mesenchymal stem cells
999,1000,NCT05191381,COVID-19|Critical Illness|Hypercytokinemia|Lung Fibrosis,Immune Modulation by Exosomes in COVID-19,Application of exosomes in a whole blood assay
